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Understanding the molecular and biophysical mechanisms that couple the process of
cell growth to cell division is one of the major challenges of modern cell biology.
Saccharomyces cerevisiae (budding yeast) has been an important model organism to
study the coupling between cell growth and cell division. The insights obtained from
studies of this unicellular organism have been pivotal for related studies in animal
systems.
The classical picture that emerged from studies in budding yeast was that cell cycle
commitment in G1, at a point called Start, requires growth to a critical cell size. This
deterministic model did not address how cell size control can be achieved despite the
stochasticity of elementary cellular processes. Furthermore, no clear connection between
the commitment at Start and the molecular network controlling the G1/S transition was
known.
We developed a novel framework for analyzing the precision of cell size control, by
combining single-cell time-lapse imaging of fluorescently labeled cells and rigorous
mathematical analysis. This allowed us to quantify the contributions of size control and
molecular noise to temporal variability of the G1 phase. Comparing wild-type and
mutant strains bearing multiple fluorescent cell cycle markers, we found that Start
regulatory dynamics can be decomposed into a size sensing module and a completely

independent timing module. We identified inactivation of the Whi5 repressor as marking
the boundary between the two modules and showed that different G1 cyclins, CLN3 vs.
CLN1 and CLN2, control the two modules. We also showed how positive feedback of G1
cyclins CLN1 and CLN2 on their own transcription ensures a fast transition between the
two modules and a coherent commitment to cell cycle progression.
Difference in cell size at birth is not the only determinant of the differential regulation
of Start between mother and daughter cell. Using single-cell analysis, microarrays and
chromatin immuno-precipitations we have shown that cell-type specific difference in
regulation of Start is also due to regulation of the G1 cyclin CLN3 by daughter-specific
transcription factors Ace2 and Ash1. This work demonstrates how asymmetric
localization of cell-fate determinants results in cell-type-specific regulation of the cell
cycle in budding yeast.
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Chapter 1: Introduction

Overview. Cells are the basic units of life and their ability to grow and reproduce is at
the basis of most biological processes. Cell reproduction occurs by an elaborate series of
events, the cell cycle, whereby cells duplicate their chromosomes and distribute them into
two newly born cells (Morgan, 2007). The discrete chromosomal processes of
duplication and segregation are often coupled to the processes of cell growth (Morgan,
2007). How cells coordinate these processes remains poorly understood (Morgan, 2007).
Unicellular organisms, such as Saccharomyces cerevisiae (budding yeast), provide ideal
experimental models to reveal the basic principles of the coordination of growth and
division (Jorgensen and Tyers, 2004). In budding yeast, the rate of cell proliferation is
determined by the rate of cell growth and not by the processes of DNA replication and
mitosis that can happen on shorter time scales than cell mass doubling time (Johnston et
al., 1977). At the core of the mechanism linking the rate of growth to cell division could
be the reliance on critical cell size for cell cycle progression (Nurse, 1975). Cell size
control imposes that cells cannot traverse a cell cycle transition until they have achieved a
critical size. In budding yeast, this point, occurring in the G1 phase, has been indicated
as Start and represents a point of commitment to the cell cycle with respect to cell
growth/size control and mating factor treatment (Johnston et al., 1977). Pre-Start cells
rapidly respond to changes in nutrient conditions and to the presence of pheromone,
while post-Start cells are insensitive to nutrient limitation or pheromone with respect to
cell cycle progression (Johnston et al., 1977).
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Cell size control and cell cycle variability. In budding yeast division is asymmetrical,
yielding a bigger mother and a smaller daughter that spends a longer period of time in the
G1 phase (Hartwell and Unger, 1977). This delay may be in part determined by cell size
or translation rate, as smaller cells spend a longer time in G1 (Hartwell and Unger, 1977;
Johnston et al., 1977).

The requirement for a critical size, however, cannot be interpreted deterministically, as
the timing of G1 shows substantial variability that is independent of cell size (Lord and
Wheals, 1981; Nurse, 1980). This variability may come from molecular noise: noise due
to small numbers of key regulatory molecules (Schroedinger, 1944; Spudich and
Koshland, 1976). Recently, many studies have shown that gene expression is a noisy
process that can generate cell-cell variability. Various insights on the origin of gene
expression noise have been obtained (Samoilov et al., 2006). Despite these insights it is
unclear what effects noise has on the precision of natural eukaryotic circuits and on the
cell cycle in particular. In Chapter 3, we present an analysis decomposing G1 variability
into size-dependent variability, which is due to size control and variable cell size at birth,
and size-independent variability, which is most likely due to molecular noise in gene
expression (Di Talia et al., 2007).

Control of Start and the G1 phase. Genetic and biochemical analyses have
decomposed the control of the G1 phase into a cascade of events culminating in
activation of budding and S-phase (Jorgensen and Tyers, 2004; Wittenberg and Reed,
2005). The G1/S transition is initiated by the G1 cyclin Cln3 that in complex with the
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cyclin-dependent kinase, Cdc28, activates the transcription factors SBF and MBF (Cross,
1995; Dirick et al., 1995; Stuart and Wittenberg, 1995; Tyers et al., 1993). Once active,
SBF and MBF activate the expression of more than 100 genes (G1/S regulon) (Spellman
et al., 1998). The G1/S regulon, which contains two additional G1 cyclins, CLN1 and
CLN2, contributes to DNA replication, budding and spindle pole body duplication (Cross,
1995; Dirick et al., 1995). To reset the cycle, the expression of SBF and MBF is shut off
by mitotic cyclins and Nrm1 (Amon et al., 1993; de Bruin et al., 2006). The activation by
Cln3 of the G1/S regulon requires the phosphorylation of promoter-bound protein
complexes, including SBF/MBF and the transcriptional inhibitor Whi5 (Costanzo et al.,
2004; de Bruin et al., 2004; Wijnen et al., 2002).

Cln3 initiates the cell cycle in a dosage-dependent manner and plays an important role
in the control of cell size (Cross, 1988, 1995; Nash et al., 1988). Overexpression or
deletion of CLN3 result in small or large cell size respectively (Cross, 1988, 1989; Nash
et al., 1988). Whi5 is one of the main targets on Cln3 activity as indicated by the fact that
the small cell size phenotype of the whi5 mutant is largely epistatic to the large cell size
phenotype of the cln3 mutant (Costanzo et al., 2004; de Bruin et al., 2004). Furthermore,
Whi5 inactivation seems to be rate limiting for SBF/MBF activation (Costanzo et al.,
2004; de Bruin et al., 2004).

G1 cyclins Cln1 and Cln2 also bind with the CDK Cdc28 and drive activation of B-type
cyclins, bud emergence and spindle pole body duplication, culminating in the transition
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from the G1 to the S phase (Cross, 1995; Dirick et al., 1995). Genetic evidence suggests
that Cln1 and Cln2 may drive these events directly (Cross, 1995).
Asymmetric transcriptional programs. Asymmetric cell division in budding yeast
yields a larger mother and a smaller daughter cell, which transcribe different genes due to
daughter-specific transcription factors, Ace2 and Ash1 (Bobola et al., 1996; ColmanLerner et al., 2001; Sil and Herskowitz, 1996). It has been shown that daughters are
slower to pass Start than mothers even when both are equally large (Lord and Wheals,
1983). This finding points to an additional source of asymmetry, other than cell size, in
Start control. In Chapter 4, we show that differential gene expression in mothers and
daughters provides such asymmetry.

Daughter-specific localization of Ash1 is achieved through active transport of ASH1
mRNA to the bud tip and consequent preferential accumulation of Ash1 in the daughter
nucleus (Cosma, 2004). Asymmetric localization of Ace2 is due to the Mob2-Cbk1
complex (Colman-Lerner et al., 2001; Mazanka et al., 2008; Weiss et al., 2002), which
prevents nuclear export of Ace2 from the daughter nucleus immediately after mitotic exit
(Colman-Lerner et al., 2001; Mazanka et al., 2008; Weiss et al., 2002). Ash1 represses
expression of the HO endonuclease gene responsible for mating type switching (Bobola
et al., 1996; Sil and Herskowitz, 1996), thus restricting HO expression to mother cells.
The transcription factor Ace2 also accumulates specifically in daughter nuclei, where it
activates a number of genes (Colman-Lerner et al., 2001).

4

Coupling observations on asymmetric gene expression and asymmetric G1 control,
Ace2 was proposed to cause a daughter-specific G1 delay (Laabs et al., 2003). In that
work, it was also proposed that Ace2-dependent delay, due to indirect repression of
CLN3, is the only determinant of the differences in G1 regulation in mothers and
daughters, and that cell size does not play a role in the regulation of G1 (Laabs et al.,
2003). This interpretation is incompatible with classical models of Start control and with
our analysis presented in Chapter 3 showing that small cells display efficient size control.
By analyzing the interaction between daughter-specific transcriptional programs, cell size
control, and irreversible commitment to the cell cycle at Start in Chapter 4 we will clarify
how asymmetric localization of cell fates determinants results in cell-type-specific
regulation of the cell cycle in budding yeast.

5

Chapter 2: Materials and Methods

Strain and plasmid constructions. Standard methods were used throughout. All
strains are of the W303 background. The plasmid pSD03 (pRS403-CLN2) was obtained
by cloning the SmaI-SfoI fragment containing CLN2 genomic DNA obtained from the
Yep24-CLN2 2μ plasmid (J. Mc Kinney unpublished data) at the SmaI site in pRS403.
The CLN2 genomic fragment started 1.4 Kb upstream of CLN2 open reading frame and
ended about 8Kb downstream. A homologous recombination pop-out of the Ty1
(retrotransposon) downstream of CLN2 was found in the original Yep24-CLN2 2μ
plasmid. pSD03 was integrated at the HIS3 locus by BglII digestion. Strain SD27-1-1A
was confirmed by Southern blot analysis to have five duplicative integrations of pSD03.
The plasmid pJB06T (pRS404-ACT1pr-DSRED) was obtained as follows. The ACT1pr
(~500 bp upstream of ACT1 open reading frame) was inserted into pTY24 (obtained from
NCRR Yeast Resource Center, University of Washington) just upstream of DSRED
coding sequence. The BamHI-BglII fragment containing ACT1pr-DSRED was then
inserted at the BamHI site in pRS404. Plasmid pSD02 (pRS406-ACT1pr-DSRED) was
obtained by cloning the BglI fragment containing ACT1pr-DSRED obtained from
pJB06T into the BglI fragment containing URA3 obtained from pRS406. pSD02 was
integrated at the URA3 locus by NcoI digestion. Tetraploid SD-tet was constructed as
follows. SD06-A-4A and SD06-B-5D were mated by cell-to-cell mating using a
micromanipulator, followed by isolation of the resulting diploid SD09. Mating type
switching was induced in SD09 cells, transformed with a 2μ plasmid carrying GAL-HO
(pJH132, kind gift from Jim Haber), by plating cells on galactose for 4 hours. Purified
6

single colonies were tested for mating type. Diploids homozygous at the mating locus
(a/a and α/α) and that lost the GAL-HO plasmid were subsequently mated by
micromanipulation to obtain the tetraploid SD-tet. This strain was confirmed to be a true
4N strain by sporulation and dissection of tetrads. Most tetrads gave 4 viable spores;
from a few tetrads in which all 4 spores were non-maters, all the progeny were
sporulated, yielding on subsequent tetrad analysis haploid MATa or MATα segregants
with high viability.

Strain SD20-1A was confirmed by Southern blot analysis to have two duplicative
integrations of pSD02. All the other strains that carry pSD02 were obtained by crosses
with SD20-1A or with strains derived from it so they also have two duplicative
integrations of pSD02. We observed that strains transformed with one copy of pJB06T
or two copies of pSD02 behave identically with the only difference that the average
intensity of the second reporter is two times larger than the average intensity of the first
one, as expected by difference in copy number. A MYO1-GFP strain was backcrossed at
least 5 times to W303 to obtain the strains used in this paper.

Plasmid pSD07 was constructed by inserting CLN3 (amplified from yeast genome by
PCR) in the pRS405-CYC1pr (kind gift of Nicolas Buchler) by XbaI and SalI digestion.
Plasmids pSD08, pSD09 and pSD10 were constructed by replacing the CYC1pr promoter
with the CDC28pr, ACT1pr and ADH1pr. ACT1pr and CDC28pr were obtained by PCR
amplification of yeast genome, while ADH1pr was obtained from pRS405-ADH1pr (kind
gift of Nicolas Buchler). Plasmid pSD13 was obtained from pSD08 by substituting the
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BglII fragment containing the LEU2 gene with the BglI fragment containing the HIS3
gene. Plasmid pSD14 was built from plasmid pMM99 (pRS414-CLN3-9xMYC, kind gift
of Mary Miller) by replacing the BglI fragment containing the TRP1 gene with the BglI
fragment containing the HIS3 gene, followed by SalI and SwaI digestion and blunt end
ligation. Plasmid pSD15 was obtained by subcloning a fragment containing the mutated
CLN3 promoter and part of CLN3 ORF (kind gift of Adam Rosenbrock and Bruce
Futcher) in FC101. Mutations of the Ash1 binding sites on the CLN3 promoter were
introduced by PCR splice overlap of FC101 or pSD15. The PCR reactions were inserted
in plasmids pSD16 and pSD17 by XbaI and BclI digestion.

All the strains expressing CLN3-9xMYC were generated by transforming in yeast
plasmid pSD14 after EcoRI digestion. These strains carry CLN3-9xMYC and a truncated
not functional CLN3. Strains carrying mutations of the Ace2/Swi5 and Ash1 binding
sites were generated by transforming in strains SD15-8A and SD15-6C plasmids pSD15,
pSD16 and pSD17 after HpaI digestion. Pop-outs were selected on 5’-FOA plates and
PCR of the CLN3 promoter region were analyzed by sequencing.

Mutations of the Ace2/Swi5 and Ash1 putative binding sites on the CLN3
promoter. We identified in the CLN3 promoter 3 putative Ace2/Swi5 binding and 2
sites that are over-represented in Ace2 and Swi5 regulated genes (data not shown). We
also found 8 putative Ash1 binding sites on the same promoter. We introduced the
following mutations of the Ace2/Swi5 putative binding sites (ATG +1): GCCAGCG
mutated to GCtAaCG (-1183), TGCTGGC mutated to TGtTaGC (-1016), GGCTGAC
mutated to GGtcaAC (-1001), TGCTGAT mutated to TGtTaAT (-766), CCCAGCC
8

mutated to CCtAaCC (-701). We introduced the following mutations of the Ash1
putative binding sites (ATG +1): ATCAA mutated to ATaAA (-1124), CTGAT mutated
to CTtAT (-969), CTGAT mutated to tTaAT (-764), ATCAG mutated to ATaAG (-591),
ATCAA mutated to ATaAA (-546), TTGAT mutated to TTtAT (-350), CTGAT mutated
to CTtAT (-23), TTGAT mutated to TTtAT (-18).

Name

Genotype

Source

MMY116-2C

MATα ADE2

SD06-A-4A
SD06-B-5D
SD08-C-12A
SD08-D-5D
SD09

MATa ACT1pr-DSRED::TRP1 MYO1-GFP::KanMX ADE2
MATα ACT1pr-DSRED::TRP1 MYO1-GFP::KanMX ADE2
MATα cln3::URA3ACT1pr-DSRED::TRP1 MYO1-GFP::KanMX ADE2
MATa cln3::URA3 ACT1pr-DSRED::TRP1 MYO1-GFP::KanMX ADE2
Diploid MATa/MATα ACT1pr-DSRED::TRP1 MYO1-GFP::KanMX
ADE2
Tetraploid MATa/MATa/MATα/MATα ACT1pr-DSRED::TRP1 MYO1GFP::KanMX ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
MATα 2xACT1pr-DSRED::URA3 MYO1-GFP::KanMX 5xCLN3::TRP1
ADE2
MATα 2xACT1pr-DSRED::URA3 WHI5-GFP::KanMX 5xCLN3::TRP1
ADE2
MATα 2xACT1pr-DSRED::URA3MYO1-GFP::KanMX ADE2
MATa 2xACT1pr-DSRED::URA3 MYO1-GFP::KanMX ADE2
MATα 2xACT1pr-DSRED::URA3 MYO1-GFP::KanMX 5xCLN2::HIS3
ADE2
MATα 2xACT1pr-DSRED::URA3 MYO1-GFP::KanMX 5xCLN3::TRP1
5xCLN2::HIS3 ADE2
MATa ACT1pr-DSRED::TRP1WHI5-GFP::KanMX cln3::URA3 ADE2
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX cln3::URA3 ADE2
MATα 2xACT1pr-DSRED::URA3 WHI5-GFP::KanMX 5xCLN2::HIS3
ADE2
MATα 2xACT1pr-DSRED::URA3 MYO1-GFP::KanMX
MET3pr-CLN2::TRP1CLN2pr-GFPPEST::HIS3 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2 ace2::URA3
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2 ace2::URA3
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2 ace2::URA3
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2 ash1::
KanMX
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2 ash1::
KanMX
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2 ash1::
KanMX
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2 ash1::
KanMX ace2::URA3

Mary
Miller
This study
This study
This study
This study
This study

SD-tet
SD15-6C
SD15-8A
SD20-1A
SD21-1-5C
SD24-1-5A
SD24-3-6A
SD27-1-1A
SD27-1-2B
SD28-3C
SD28-5A
SD29-1-2A
JS19
SD57-2D
SD57-3B
SD57-9B
SD76-1-1C
SD76-1-5A
SD76-3-12B
SD58-5-2A
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This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Jan
Skotheim
This study
This study
This study
This study
This study
This study
This study

SD33-1D

FC2147-7C

MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
ace2::HIS3::ACE2G128E::URA3
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
ace2::HIS3::ACE2G128E::URA3
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
ace2::HIS3::ACE2G128E::URA3
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
ash1:: KanMX ASH1-MUT::LEU2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
Ace2::HIS3::ACE2G128E::URA3 ash1:: KanMX ASH1-MUT::LEU2
MATα cdc20::LEU2 GALL-CDC20::ADE2

SD59-6C
SD60-4C
SD62-7C
SD42-7A
SD73-8A
SD74-9C
JB55-4C

MATa cdc20::LEU2 GALL-CDC20::ADE2 ACE2-YFP::URA3
MATα cdc20::LEU2 GALL-CDC20::ADE2 SWI5-GFP::KanMX
MATα cdc20::LEU2 GALL-CDC20::ADE2 ASH1-GFP::KanMX
MATα MYO1-mCherry::HIS5 ACE2-YFP::URA3 ADE2
MATa MYO1-mCherry::HIS5 SWI5-GFP::KanMX ADE2
MATa MYO1-mCherry::HIS5 ASH1-GFP::KanMX ADE2
MATα cdc20::LEU2 GALL-CDC20::ADE2 ace2::URA3

JB55-8A

MATa cdc20::LEU2 GALL-CDC20::ADE2 swi5::KanMX

JB55-13C

MATα cdc20::LEU2 GALL-CDC20::ADE2 swi5::KanMX ace2::URA3

SD49-1-1B

MATα cdc20::LEU2 GALL-CDC20::ADE2
ace2::HIS3::ACE2G128E::URA3
MATa cdc20::LEU2 GALL-CDC20::ADE2 ash1:: KanMX HOpr-CAN1
HOpr-ADE2
MATa cdc20::LEU2 GALL-CDC20::ADE2 ash1:: KanMX ASH1MUT::LEU2
HOpr-CAN1 HOpr-ADE2
MATa cdc20::LEU2 GALL-CDC20::ADE2 ACE2-TAP::HIS3
MATα cdc20::LEU2 GALL-CDC20::ADE2 SWI5-TAP::HIS3
MATa cdc20::LEU2 GALL-CDC20::ADE2 ASH1-TAP::HIS3
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX CLN39xMYC::HIS3 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX CLN39xMYC::HIS3 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
ACT1pr-CLN3-9xMYC::HIS3::LEU2 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
ACT1pr-CLN3-9xMYC::HIS3::LEU2 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
ADH1pr-CLN3-9xMYC::HIS3::LEU2 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
ADH1pr-CLN3-9xMYC::HIS3::LEU2 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
CDC28pr-CLN3-9xMYC::HIS3::LEU2 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
CDC28pr-CLN3-9xMYC::HIS3::LEU2 ADE2
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
cln3::URA3 CDC28pr-CLN3::LEU2 5xCDC28pr-CLN3::HIS3 ADE2
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
cln3::URA3 CDC28pr-CLN3::LEU2 3xCDC28pr-CLN3::HIS3 ADE2

SD33-2A
SD33-5C
SD50-13C
SD50-11A

SD51-10B
SD51-12B
SD52-2A
SD53-3B
SD72-9C
SD65-1
SD65-2
SD66-1
SD66-2
SD67-1
SD67-2
SD71-1
SD71-2
SD75-1
SD75-3
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This study
This study
This study
This study
This study
Frederick
Cross
This study
This study
This study
This study
This study
This study
James
Bean
James
Bean
James
Bean
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

SD54-1
SD54-2
SD80-1
SD80-2
SD81-1
SD81-2
SD82-1
SD82-2

MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
cln3::URA3 ADH1pr-CLN3::LEU2 ADE2
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX
cln3::URA3 ADH1pr-CLN3::LEU2 ADE2
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
Ace2/Swi5 binding sites deleted on the CLN3 promoter
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
Ace2/Swi5 binding sites deleted on the CLN3 promoter
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
Ash1 binding sites deleted on the CLN3 promoter
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
Ash1 binding sites deleted on the CLN3 promoter
MATa ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
Ace2/Swi5 and Ash1 binding sites deleted on the CLN3 promoter
MATα ACT1pr-DSRED::TRP1 WHI5-GFP::KanMX ADE2
Ace2/Swi5 and Ash1 binding sites deleted on the CLN3 promoter

This study
This study
This study
This study
This study
This study
This study
This study

Table 2.1 Strain list. All strains are congenic W303 (leu2-3,112 his3-11,15 ura3-1 trp11 can1-1).

Name

Description

Construction

pJB06T
pTY24

pRS404-ACT1pr-DsRed
DsRed source plasmid

pSD02
pSD03
pJH132
p405CYC1
pSD07
pSD08
pSD09
p405ADH1
pSD10
pSD13
pMM99
pSD14
FC101

pRS406-ACT1pr-DsRed
pRS403-CLN2
YCp50-GAL-HO
pRS405-CYC1pr
pRS405-CYC1pr-CLN3
pRS405-CDC28pr-CLN3
pRS405-ACT1pr-CLN3
pRS405-ADH1pr
pRS405-ADH1pr-CLN3
pRS403-CDC28pr-CLN3
pRS414-CLN3-9xMYC
pRS403-truncated CLN3-9xMYC
YCp50 without centromere +6.5 Kb CLN3
genomic region
FC101 with Ace2/Swi5 sites on the CLN3
promoter mutated
FC101 with Ash1 sites on the CLN3 promoter
mutated
FC101 with Ace2/Swi5 and Ash1 sites on the
CLN3 promoter mutated

see above
NCRR Yeast Resource Center,
University of Washington
see above
see above
kind gift from Jim Haber
Nicolas Buchler
see above
see above
see above
Nicolas Buchler
see above
see above
Mary Miller
see above
Fred Cross

pSD15
pSD16
pSD17

Table 2.2 Plasmid list
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see above
see above
see above

Time-lapse microscopy. Preparation of cells and time-lapse microscopy were
performed as previously described (Bean et al., 2006). Detection of GFP and DsRed
fluorescence was by illumination with a 100 W short arc mercury lamp type 103 W/2.
Illumination was passed through a Chroma neutral density filter ND 2.0 allowing 1%
transmission and either a Chroma EGFP filter set #41001 (peak excitation wavelength at
480 nm, peak emission at 535 nm) or a Chroma TRITC filter set #41002c (peak
excitation wavelength at 545 nm, peak emission at 620 nm). The frame rate was
1frame/3min for cells grown in glucose and 1frame/6min for cells grown in
glycerol/ethanol. The exposure time was 1 second for GFP and 0.35 seconds for DsRed
for cells grown in glucose and 0.4 seconds for GFP and 0.1 seconds for DsRed for cells
grown in glycerol/ethanol (cells grown in glycerol/ethanol were more sensitive to light
damage). Fluorescent images of strains grown in glycerol/ethanol were acquired by 2x2
binning of camera pixels, which allows detection of Myo1-GFP and Whi5-GFP using
reduced exposure times. With these exposures the two chromophores were well
separated and we did not observe any significant photo-toxicity or perturbations of cell
cycle timing except for a few sporadic cells having a long budded period, perhaps due to
damage from illumination. These events did not affect our quantitative or qualitative
results.

Image analysis. Automated image segmentation and fluorescence quantification of
yeast grown under time-lapse conditions and semi-automated assignment of microcolony
pedigrees were performed as previously described. Budding and division were scored by
visual inspection for the appearance and disappearance of the Myo1-GFP signal at the
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bud neck. The detection of the Myo1-GFP signal was facilitated by setting pixels whose
value was smaller than a suitably chosen threshold (median+1.5 standard deviations of
cell fluorescence values) to zero (black color). The remaining pixels were plotted in gray
scale with white color assigned to the highest pixel value. The ring disappearance was
easy to score. Myo1-GFP appearance at the bud neck was usually detected for the first
time 6-9 minutes before budding could be scored by visual inspection. Uncertainty in the
ring appearance was confined to 1-2 frames for most cells. Occasional cells that budded
upwards in the middle of the colony were hard to score. We consistently decided not to
score cells for which the uncertainty on the ring appearance was bigger than 2-3 frames.
The nuclear residence of Whi5-GFP was scored by visual inspection of composite phase
contrast-fluorescent movies and confirmed by the method described for Myo1-GFP
detection.

Data analysis. Time-lapse fluorescence microscopy and microarray data were analyzed
with custom software written in MATLAB software (see Appendix for detail on the
analysis of fluorescence-based measurements of cell size). For cluster analysis, the log2
of the arrays data or of the subtracted arrays data were hierarchically clustered by
agglomerative algorithm (Eisen et al., 1998). Data were visually presented using
JavaTreeView.

Cell cycle synchronization. YEP medium was used for all the cell cycle
synchronization experiments, supplemented with the appropriate carbon source as
indicated below. Cell-cycle synchronization was achieved by the cdc20 GALL-CDC20

13

block release by growing cells to early log phase in YEP + galactose (3%) and then
filtering them and growing them in YEP + glucose (2%) for 3 hr to arrest cells in
metaphase. Cells were released from the block by filtering back into YEP + galactose
(3%). GALL is a truncated version of the GAL1 promoter that shows inducible but
significantly lower expression than the full-length GAL1 promoter (Mumberg et al.,
1994).

Gene arrays. Microarrays were performed at the Stony Brook Microarray facility as
previously described (Oliva et al., 2005).

Chromatin immunoprecipitations. Chromatin immunoprecipitations (ChIP) were
performed by Hongyin Wang (Di Talia et al., in preparation).
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Chapter 3: Size control and molecular noise in Start of the
budding yeast cell cycle.
Control of the G1 phase in the budding yeast cell cycle has been classically attributed to
a size sensing mechanism that assures that cells progress through a commitment point in
G1, called Start, after having achieved a critical size or translation rate (see Chapter 1).
However, cell cycle intervals in budding yeast exhibit substantial variability even when
cell size is taken into account (Wheals, 1982). In this Chapter, we present a quantitative
characterization of the roles of cell size control and molecular noise in generating and
controlling variability of the G1 phase of the cell cycle. We show that variability in G1
decreases with the square root of the ploidy, consistent with simple stochastic models for
molecular noise and that increasing G1 cyclin gene dosage also decreases G1 variability.
By using a novel single-cell reporter for cell size we determine the contribution to
temporal G1 variability of deterministic size control (i.e. smaller cells extending G1) and
molecular noise. Size-independent (molecular) noise is the largest quantitative
contributor to G1 variability. We finally show that Start regulatory dynamics can be
decomposed into two independent modules, a size sensing module and a timing module,
each predominantly controlled by different G1 cyclins.

The effects of molecular noise on the variability of cell cycle timing. Molecular
noise in gene expression (Samoilov et al., 2006) of critical regulatory molecules, due to
small numbers of molecules (e.g. transcription factors bound or not bound to promoters,
small numbers of mRNA molecules), could in principle be a significant generator of cell
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cycle variability. To study if noise in gene expression generates significant cell cycle
variability, we measured the variability of cell cycle timing in yeast cells of different
ploidy. Doubling ploidy is known to double the average content of all cellular
constituents (RNA, protein, etc.); cell volume also doubles, so that average
concentrations remain constant. If stochastic variations in small numbers of molecules
control noise in gene expression (Schroedinger, 1944; Spudich and Koshland, 1976), then
doubling the average should reduce the noise (standard deviation divided by the mean) in
gene expression by about √2. This prediction follows from the fact that for a large class
of stochastic processes (such as Poisson or Bernoulli processes) the standard deviation
increases as √n, where n indicates the number of molecules. As a consequence, the
variability scales as 1/√n. We can therefore predict that doubling ploidy will reduce
variability in gene expression by about √2 resulting in reduction of the cell cycle noise by
a similar factor, if molecular noise in gene expression contributes significantly to overall
cell cycle variability.

We measured times from cytokinesis to budding (G1) and from budding to cytokinesis
in haploids, diploids or tetraploids (mothers and daughters), using time-lapse
fluorescence microscopy of strains expressing Myo1-GFP. Myo1 forms a ring at the new
bud neck (Bi et al., 1998) (concomitant with initiation of DNA replication (Johnston et
al., 1977)), which disappears at cytokinesis (Bi et al., 1998) (Figure 3.1, Table 3.1). G1
variability is reduced in both mothers and daughters by about the expected factor of √2
for each ploidy doubling (Figure 3.1, Table 3.2, Figure 3.2). Thus molecular noise may
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Figure 3.1 Noise in G1 duration is reduced by increased ploidy. a) Composite phase
contrast, Myo1-GFP and ACT1pr-DsRed images for haploid cells, b) Illustration of
measured intervals. (c-h): Frequency histograms (n from 87-202) of the duration of G1
for wild-type haploid (c,f), diploid (d,g) and tetraploid (e,h), daughters (c,d,e) and
mothers (f,g,h). Insets: average and the coefficient of variation (CV: the standard
deviation divided by the mean, a standardized noise measure).

17

G1 daughter
Budded period daughter
G1 mother
Budded period mother
Total cycle daughter
Total cycle mother

Haploids

Diploids

Tetraploids

37±2 (158)
76±2 (97)
15.6±0.5 (202)
72±1 (116)
112±3(97)
87±1 (116)

25.7±0.8 (164)
81±1 (95)
14.1±0.4 (184)
71±1 (105)
106±2 (95)
85±1 (105)

30.5±0.8 (100)
82±2 (52)
16.2±0.4 (104)
74±2 (54)
113±2 (52)
90±2 (54)

Table 3.1 Average cell cycle periods for cells of different ploidy. The table shows the
mean +/- standard error of the mean in minutes with the number of observations reported
in parenthesis.

Coefficient of variation
G1 daughter
Budded period daughter
G1 mother
Budded period mother
Total cycle daughter
Total cycle mother

Haploids
0.50±0.05 (158)
0.20±0.06 (97)
0.50±0.05 (202)
0.17±0.02 (116)
0.22±0.02(97)
0.14±0.01 (116)

Diploids
0.41±0.04 (164)
0.17±0.05 (95)
0.42±0.4 (184)
0.16±0.02 (105)
0.16±0.01 (95)
0.13±0.02 (105)

Tetraploids
0.26±0.03 (100)
0.15±0.04 (52)
0.28±0.03 (104)
0.15±0.02 (54)
0.14±0.02 (52)
0.14±0.02 (54)

Table 3.2 Coefficient of variation of cell cycle periods for cells of different ploidy.
The number of observations is reported in parenthesis.

be a major source of G1 variability. In marked contrast, variability in the time from
budding to cytokinesis is nearly unaffected by ploidy (Table 3.2). These results suggest
that molecular noise is a major contributor to the variability of the G1 phase of the cell
cycle, but that other sources of noise, such as morphological transitions, may play an
important role in determining the timing of the budded phase (approximately S/G2/M).
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Figure 3.2 Molecular noise is responsible for most of the fluctuations of the duration
of G1 period. Plot of the noise (coefficient of variation: CV) as a function of ploidy for
the duration of G1 (CVG1), for the duration of G1 scaled to the growth rate, CVαT and for
the portion of this noise that is size and growth rate-independent and can be attributed to
molecular noise (see Table 3.7) (i.e., this is variation about the αT vs. ln(Mbirth) line for
cells of varying ploidy). The black lines are curves ~1/√ploidy.

Noise in the expression of G1 cyclins contributes to the variability of G1. The
magnitude and ploidy sensitivity of G1 noise suggest that the noise might be due to small
variable numbers of key regulatory molecules. G1 cyclins (Cln1, Cln2 and Cln3) control
average G1 duration (see Chapter 1). Cln3, in complex with the Cdc28 Cdk, is the most
upstream activator of Start. Cln3/Cdc28 promotes the transcription of G1 cyclins CLN1

19

and CLN2 as well as many other genes (Koch et al., 1996; Spellman et al., 1998; Wijnen
et al., 2002). Cln1,2/Cdc28 complexes drive bud emergence, microtubule organization
center duplication and activation of B type cyclins which initiate DNA replication (Cross,
1995; Dirick et al., 1995).

Since G1 cyclins are expressed at a few mRNA transcripts per cell (Holstege et al.,
1998), molecular noise in their expression could account for G1 variability, and its
ploidy-dependent reduction. If this is so, integration of multiple copies of G1 cyclin
genes in a haploid genome should reduce the variability of G1, by reducing variability in
the expression of these critical genes, even while all other genes remain at single copy.

We quantified cell cycle time variability in haploid strains containing integrated arrays
of 5 copies of CLN3, 5 copies of CLN2, or both, in addition to the normal copies. A
strain carrying 6 copies of CLN3 exhibited strongly reduced G1 variability in daughter
cells, but mother cell G1 variability was much less affected (Figure 3.3). In contrast, G1
variability in a strain with six copies of CLN2 showed a very strong reduction of noise in
mother cells but a smaller reduction of noise in daughter cells (Figure 3.3). Noise in a
strain having six copies of both CLN3 and CLN2 is reduced in both mothers and
daughters (Figure 3.3).
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Figure 3.3 Noise in G1 duration is reduced by increasing the number of copies of G1
cyclins. a), A map of the core molecular network driving Start. Histograms of the G1
duration for daughters: wt (b), 6xCLN3 (c), 6xCLN2 (d), 6xCLN3 6xCLN2 (e).
Histograms of the G1 duration for mothers: wt (f), 6xCLN3 (g), 6xCLN2 (h), 6xCLN3
6xCLN2 (i). For every histogram we report the number of measurements, the average G1
duration and the coefficient of variation (standard deviation divided by the mean).
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Whi5 enters the nucleus late in mitosis, about 6 minutes before cytokinesis (Figure 3.4),
and Cln3/Cdc28 initiates Whi5 nuclear exit and SBF/MBF activation in the succeeding
cell cycle (Costanzo et al., 2004; de Bruin et al., 2004). We used a Whi5-GFP fusion
(Bean et al., 2006; Costanzo et al., 2004) to quantify the timing of Whi5 nuclear
residence in mothers and daughters (Figure 3.4). In mother cells, Whi5 exits the nucleus
within few minutes after cytokinesis (Table 3.3) and as a consequence the length of G1 in
mothers is mainly determined by the post-Whi5 nuclear exit period. Daughter cells, in
contrast, exhibit a significant duration of Whi5 nuclear residence (20 min on average).
This period was reduced to 10 min in 6X CLN3 daughters; in 6X CLN2 daughters Whi5
nuclear residence was closer to that in wild-type (16 min). Consistent with previous data
(Bean et al., 2006), deletion of cln3 significantly increased average Whi5 nuclear
residence time in both mothers and daughters (average 13 and 30 min respectively). The
latter result indicates that Cln3 is functioning in both mothers and daughters to drive
Whi5 nuclear exit, but that the Cln3 requirement is attained almost immediately upon cell
division in mothers, while requiring a significant period in daughters.

The observations on Whi5 nuclear residence in mothers and in daughters of differing G1
cyclin gene dosage can be integrated with the observations on the effects of G1 cyclin
dosage on variability of G1 by the following model. We propose a decomposition of
Start into two steps, a Cln3-dependent step (fast in mothers, slow in daughters), the
conclusion of which is marked by Whi5 nuclear exit, and a Cln2-dependent step that may
have similar duration and variability in mothers and daughters. In daughters, the
durations of the pre-Whi5 exit and post-Whi5 exit periods are highly variable and
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Figure 3.4 The regulation of Whi5 nuclear residence. a) Composite phase contrast,
Whi5-GFP and ACT1pr-DsRed images for haploid cells; Whi5-GFP is mostly observed
in new-born daughter cells; b) Diagram of the measured intervals; TG1 (Figure 3.1) is
approximately T1 + T2. c) Histogram of the duration of the interval from Whi5 nuclear
entry to Myo1 disappearance. d) Scatter plot of T1 and T2 for daughter cells, showing that
they are uncorrelated.
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T1 in daughters
T1 in mothers
T2 in daughters
T2 in mothers

wt
20±1 (157)
0.9±0.3 (170)
17±2 (157)
14.7±0.6 (170)

cln3
30±4 (47)
13±1 (55)
14±2 (47)
13±1 (55)

6xCLN3
10±1 (53)
0.7±0.5 (56)
16±1 (53)
13.6±0.8 (56)

6xCLN2
16±1 (80)
1.1±0.4 (90)
11±1 (80)
12.0±0.6 (90)

Table 3.3 Average durations of the period from cytokinesis to Whi5 nuclear exit (T1)
and the period from Whi5 exit to bud emergence (T2) in different strains. T1 and T2
are diagrammed in Figure 3.4. Mean +/- standard error of the mean in minutes (number
of observations).

independent (correlation coefficient -0.1, see Figure 3.4), consistent with Whi5 exit
marking the boundary between two separate steps. This model accounts for CLN3dependent reduction of G1 noise preferentially in daughters, because the pre-Whi5-exit
period is very short in mothers; CLN2-dependent reduction of G1 noise preferentially in
mothers could come about because almost the entire G1 period in mothers is dependent
on CLN2, while only a portion of G1 in daughters is affected by CLN2.

A new metric for the analysis of cell size control. The previous analysis was based
solely on timing; however, cell size has long been proposed as a deterministic regulator
of Start (Hartwell and Unger, 1977; Johnston et al., 1977; Jorgensen and Tyers, 2004).
While traditional analysis of yeast cell size has been largely based on cell volume, we
were concerned that cell volume does not directly reflect intra-cellular protein content; in
cells with large vacuoles, this will clearly not be the case (Han et al., 2003). Therefore, to
provide a protein-based single cell marker of cell size, we placed the DsRed Red
Fluorescent Protein under control of the constitutive, strongly expressed ACT1 promoter.
Assuming that DsRed transcript accumulates and is translated in parallel with bulk

25

cellular mRNA, then total red fluorescence per cell will reflect total cell protein content
(see Appendix). Quantifying total red fluorescence per cell using the semi-automated
image analysis program described previously (Bean et al., 2006), we observed
exponential growth in single cells (Figure 3.5a; see Appendix), as deduced previously
from pulse-labeling of size-selected populations (Elliott and McLaughlin, 1978). The
single-cell growth rate α is moderately variable, but its average agrees well with the bulk
culture growth rate (Figure 3.5b, see Appendix). Total red fluorescence scales linearly
with ploidy (Table 3.4) and with geometric estimates of cell size (see Appendix).
However, using our methods, DsRed fluorescence is a more reliable indicator of cell size
than geometric volume estimation (see Appendix). Total red fluorescence for a colony
increases exponentially (Figure 3.5c), so changes in the microenvironment do not
interfere with these measurements. These results support the use of total red fluorescence
from ACT1pr-DsRed as a single-cell marker for cell size.

Size control at Start would require smaller cells to prolong G1 for growth, thereby
linking birth-size and G1 duration. Given exponential growth, the size at budding, Mbud,
is related to the size at birth Mbirth, through the amount of time spent in G1 via the simple
formula: Mbud = Mbirth eαT_G1, where α is the growth rate for exponential growth. This
expression yields: αTG1 = ln(Mbud) - ln(Mbirth). Plotting correlations between αTG1 and
ln(Mbirth) allows us to distinguish between two classical concepts for G1 control: timers
and sizers (Donnan and John, 1983; Sveiczer et al., 1996). If G1 duration is under
control of a timer, then αTG1 is independent of cell size at birth, and the slope of the linear

26

fit of the plot of αTG1 vs. ln(Mbirth) will be 0. In contrast, if G1 is controlled by a sizer, all
cells

Figure 3.5 The correlation between cell size and G1 duration demonstrates a noisy
size control operative in daughters. a) Logarithm of total DsRed fluorescence (M) per
cell in a single representative cell from birth to cytokinesis. Doubling time is ln(2)/α; α is
the slope of this line; b) haploid cell doubling time distribution. c) Total DsRed
fluorescence in an entire colony over time; d, e) correlation between αTG1 (growth-ratestandardized time in G1) and ln(M) for haploid mothers (d) and daughters (e) at birth
(‘ln(Mbirth)’) (insets: binned data); f) the data from (e) (solid blue dots), supplemented
with data from unusually small wild-type haploid daughters (open green circles),
generated using essentially the method of Dirick et al. (1995). Statistical analysis and
estimated slopes in Tables 3.5 and 3.6.

will bud at the same size Mbud, independent of their size at birth, implying that the slope
of the linear fit of αTG1 vs. ln(Mbirth) will be -1 (Sveiczer et al., 1996).
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For the following analysis, rigorous statistical testing of fits and estimated slopes are
reported in Tables 3.5, 3.6. Scaled G1 duration in mother cells is essentially independent
of cell size (slope ≈ -0.1), demonstrating ‘timer’ control of mother G1 (Figures 3.5d, 3.8).
Daughters, in contrast, demonstrate significant size control (slope ≈ -0.4). Binning the
daughter data (Figure 3.5e inset) suggested decomposition into two segments, one for
small newborn daughters (< 67% of the average budding size), in which an efficient sizer
was deduced (slope ≈ -0.7), and a second segment for larger-born daughters showing
much less dependence on cell size (slope ≈ -0.3) (Figure 3.5e, 3.9). Statistical confidence
in this decomposition was limited by the small number of very small daughters obtained;
therefore, we employed the genetic method of Dirick et al. (1995) to make unusually
small wild-type daughter cells by transient expression of conditional MET3pr-CLN2
(Dirick et al., 1995). Inclusion of these data (Figure 3.5f) provided strong statistical
support for the 2-slope model (linear fit: P<0.05; 2-slope fit: P>0.7, see also Table 3.5).
These observations are robust to changes in nutrient conditions: growth of cells in
glycerol/ethanol instead of glucose, resulting in slow growth and generation of very small
newborn daughter cells, gave quantitatively similar results, supporting a two-slope model
for daughter G1 control (Figure 3.6, Table 3.5). Remarkably, the data for glycerolethanol grown daughters fell on the same quantitative line as that already established for
glucose-grown cells, implying a growth-rate-independent size control mechanism
operating over a wide range of daughter cell sizes (Figure 3.6). This is true also for
tetraploid cells, which usually do not display unusually small daughter cells, supporting
the idea that a two-slope model describes well daughter G1 control also in cells of higher
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ploidy (Figure 3.7). Even in glycerol-ethanol, mother cells exhibit no evidence of size
control.

wt haploids
wt diploids
wt tetraploids
6xCLN2
6xCLN3
6xCLN3 6xCLN2

Average size at bud
1.00±0.06
2.0±0.1
3.9±0.1
0.94±0.06
0.77±0.05
0.81±0.05

Table 3.4 Average sizes at budding for various strains. The data were normalized to
the average size at budding of wt haploid cells. The comparison was done only for cells
imaged the same day to reduce variation due to the illumination source. The table shows
the mean +/- standard error of the mean.

αT1 vs. ln(Mbirth) haploid wt dataset

One-slope model
P=0.05

Two-slope model
P=0.65

αT1 vs. ln(Mbirth) haploid wt glucose +
P=2∙10-5
P=0.07
glycerol/ethanol datasets
αTG1 vs. ln(Mbirth) haploid wt+small
P=0.02
P=0.72
MET3pr-CLN2 daughters datasets
αTG1 vs. ln(Mbirth) haploid wt glucose +
P=1∙10-5
P=0.22
glycerol/ethanol datasets
αTG1 vs. ln(Mbirth) tetraploid wt glucose
P=2∙10-7
P=0.06
+ glycerol/ethanol datasets
Table 3.5 A two-slope model fits the correlation between αTG1 and αT1 with the
ln(Mbirth) of daughter cells better than a one-slope model. The table shows the pvalues of a Pearson’s χ2 test using a one-slope or two-slope model.
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wt mothers

αTG1 vs. ln(Mbirth)
-0.13 (-0.20:-0.08)

αT1 vs. ln(Mbirth)
-0.06 (-0.09:-0.02)

wt daughters
small wt daughters
big wt daughters
small wt+MET3pr-CLN2daughters
big wt+MET3pr-CLN2daughters
small wt in D+g/e daughters
big wt in D+g/e daughters
small tetraploid daughters in D+g/e
big tetraploid daughters in D+g/e
6xCLN3 daughters
6xCLN3 small daughters
6xCLN3 big daughters
whi5 daughters
whi5 small daughters
whi5 big daughters

-0.38 (-0.49:-0.24)
-0.69 (-1.10:-0.27)
-0.32 (-0.52:-0.12)
-0.84 (-1.10:-0.58)
-0.36 (-0.56:-0.17)
-0.84 (-1.01:-0.67)
-0.31 (-0.48:-0.13)
-0.79 (-1.12:-0.47)
-0.26 (-0.37:-0.14)
-0.25 (-0.34:-0.16)
-0.34 (-0.52:-0.12)
-0.33 (-0.54:-0.13)
-0.23 (-0.30:-0.15)
-0.22 (-0.43:-0.02)
-0.22 (-0.39:-0.05)

-0.43 (-0.56:-0.31)
-0.66 (-1.00:-0.30)
-0.20 (-0.37:0.00)
N/A
N/A
-0.72 (-1.02:-0.46)
-0.25 (-0.38:-0.13)
N/A
N/A
-0.19 (-0.31:-0.06)
-0.31 (-0.51:-0.11)
-0.30 (-0.56:-0.06)
N/A
N/A
N/A

Table 3.6 Values of the estimated slopes for the correlation of αTG1 and αT1 with the
ln(Mbirth). The table shows the values of the slopes and their 95% confidence bounds.
The figures with the raw and binned data are referenced in parenthesis. All the strains are
haploid except when indicated. (D = glucose, g/e = glycerol/ethanol).
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Figure 3.6 A two-slope model describes the correlation of αT1 or αTG1 with ln(Mbirth)
better than a one-slope model. a) Two-slope model fit or one-slope model fit of binned
data of αTG1 vs. ln(Mbirth) combining the data obtained with the MET3pr-CLN2 strain and
with the wt strain, b) combination of data sets of wt cells grown in glucose (blue closed
circles) and in glycerol/ethanol (black open circles) for αTG1 vs. ln(Mbirth), c) two-slope
model fit or one-slope model fit of binned data of αTG1 vs. ln(Mbirth) combining the wt
data obtained for cells grown in glucose and in glycerol/ethanol (data from b)), d) twoslope model fit or one-slope model fit of binned data of αT1 vs. ln(Mbirth) for glucose
grown cells, e) combination of data sets of wt cells grown in glucose (green closed
circles) and in glycerol/ethanol (black open circles) for αT1 vs. ln(Mbirth), f) two-slope
model fit or one-slope model fit of binned data of αT1 vs. ln(Mbirth) combining the wt data
obtained for cells grown in glucose and in glycerol/ethanol (data from e)).
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Figure 3.7 A two-slope model describes the correlation of αTG1 with the ln(Mbirth)
for tetraploid cells better than a one-slope model. a) Combination of data sets of wt
tetraploid cells grown in glucose (blue circles) and in glycerol/ethanol (green circles) for
αTG1 vs. ln(Mbirth), b) two-slope model fit or one-slope model fit of binned data of αTG1
vs. ln(Mbirth) combining the data obtained for cells grown in glucose and in
glycerol/ethanol (data from a)).

Decomposition of G1 variability in size-dependent and size-independent noise.
Efficient size control ensures that all cells bud at the same size. Since there is variability
in cell size at birth, an efficient sizer would ensure that smaller cells spend longer in G1,
generating cell-to-cell variability in G1 duration. Measuring individual growth rates and
cell sizes allows decomposition of G1 variability into variability due to size control and a
size-independent residual attributable to molecular noise. Assuming G1 duration for an
individual cell is the sum of a deterministic function of cell size at birth, f(Mbirth), and
stochastic variable, η, then: αTG1=f(Mbirth)+ η, where f(Mbirth) is obtained empirically by
binning data. For a measured distribution of sizes at birth, the variance of f(Mbirth) yields
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the amount of G1 variability produced by size control. Size-independent variability is the
average distance between a data point and the deterministic f(Mbirth).

This decomposition shows that size-independent (presumably molecular) noise is the
leading source of variability in the duration of G1 in both mothers and daughters (Table
3.7). However, size control accounts for about 30-40% of overall G1 variability in
daughters. Consistent with our previous timing analysis, size-independent noise
decreases by approximately a factor of √2 for each ploidy doubling (Table 3.7; Figures
3.2,3.8,3.9); thus, ploidy-dependent noise reduction is robust to statistical removal of all
detectable size and growth rate effects, strongly suggesting that molecular noise explains
size-independent variability. G1 cyclin gene dosage also decreases size-independent
variability; therefore, some of this variability may be attributable to stochastic variation
in the expression of G1 cyclins themselves, although other targets cannot be excluded.
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DAUGHTERS
wt haploids
wt diploids
wt tetraploids
haploid 6xCLN2
haploid 6xCLN3
haploid 6xCLN3
6xCLN2
MOTHERS
wt haploids
wt diploids
wt tetraploids
haploid 6xCLN2
haploid 6xCLN3
haploid 6xCLN3
6xCLN2

G1 noise,
birth to
budding
(coefficient of
variation of
αTG1)

Noise due to
size control
(percentage of
the total
variance of
αTG1)

Size and growth
rate-independent
noise (percentage
of the total
variance of αTG1)

0.55±0.06
0.42±0.04
0.24±0.02
0.48±0.04
0.44±0.04
0.37±0.03

0.31±0.04
0.28±0.03
0.15±0.01
0.30±0.03
0.25±0.02
0.18±0.02

0.45±0.04
0.31±0.03
0.19±0.02
0.37±0.03
0.36±0.03
0.32±0.03

0.50±0.05
0.39±0.04
0.26±0.02
0.33±0.03
0.48±0.05
0.34±0.03

0.20±0.02 (16)
0.13±0.01 (11)
0.09±0.01 (12)
0.13±0.01 (16)
0.16±0.02 (11)
0.17±0.02 (25)

(32)
(45)
(39)
(39)
(32)
(24)

(68)
(55)
(61)
(61)
(68)
(76)

0.46±0.04 (84)
0.37±0.04 (89)
0.24±0.02 (88)
0.30±0.03 (84)
0.45±0.04 (89)
0.29±0.02 (75)

Table 3.7 Decomposition of G1 variability into a deterministic size control term and
a residual attributable to molecular noise. G1 noise (column 1): coefficient of
variation in αTG1, (α: growth rate; TG1 G1 duration). G1 noise is decomposed into sizedependent and size-independent components (columns 2,3); in parentheses, the
percentage of the variance of αTG1 accounted for in each column. (Noise in αTG1 is the
square root of the sum of the squares of the two independent noise contributions.
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Figure 3.8 Size independent noise is reduced by ploidy and by increasing the
number of copies of G1 cyclins in mother cells. Correlation between the duration of
G1, TG1, scaled to the growth rate, α, and the logarithm of cell size at birth shows the lack
of size control in mother G1 and that cell size independent noise (Table 3.7) is reduced
by ploidy and by increasing the number of copies of G1 cyclins. The size of all haploid
strains was normalized to the average size at budding of wt cells. The size of diploid and
tetraploid cells was normalized to the average size at budding of diploid and tetraploid
cells respectively.
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Figure 3.9 Size independent noise is reduced by ploidy and by increasing the
number of copies of G1 cyclins in daughter cells. Correlation between the duration of
G1, TG1, scaled to the growth rate, α, and the logarithm of cell size at birth shows that cell
size independent noise (Table 3.7) is reduced by ploidy and by increasing the number of
copies of G1 cyclins. An inverse correlation (significantly different from both 0 and -1)
is observed for all the strains and is indicative of a ‘sloppy’ size control. The size of all
haploid strains was normalized to the average size at budding of wt cells. Small wt
daughter cells exhibit an efficient size control (slope= - 0.7). Cells with more copies of
CLN3 no longer show efficient size control (slope= - 0.3), indicating that CLN3 gene
dosage alters the properties of size control. In contrast, increasing CLN2 gene dosage
does not alter size control (see also Figure 3.11). The size of diploid and tetraploid cells
was normalized to the average size at budding of diploid and tetraploid cells respectively.
The lack of a clear component of high negative slope for smaller daughter cells in
diploids and tetraploids is not fully understood, but may be largely due to the lack of
unusually small daughter cells generated by these higher-ploidy cells, due to a slightly
longer budded period during which the bud grows, combined with a reduction in
variability of growth rate of individual cells (see Table 3.1 and Appendix). These
explanations do not account for the lack of this slope in 6X CLN3 and 6X CLN3 6X CLN2
cells. We have tested this explanation by growth of tetraploids in glycerol/ethanol
(Figure 3.7) where we find that combining the small daughters obtained from
glycerol/ethanol growth with the larger daughters obtained from glucose growth gives a
continuous data set well fit with two slopes.
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G1 dynamics is composed of two modules: a size-sensing and a timing module. We
can divide G1 into two steps, T1 and T2, based on nuclear residence of Whi5 (Bean et al.,
2006; Costanzo et al., 2004), which enters the nucleus late in mitosis and exits during G1
(Costanzo et al., 2004) (Figure 3.4). Since T1 and T2 are uncorrelated, Whi5 exit marks
the boundary between two independent steps in daughters (Figure 3.4d). For daughters,
plotting T1, the time from birth to Whi5 nuclear exit scaled with the growth rate vs.
the logarithm of the size at birth, yields a nearly identical relationship to that for overall
G1 duration TG1 (Figure 3.10 a-c), shifted down due to growth during T2. The indicated
two-slope model fits these data significantly better than a one-slope model, and the
deduced slopes for the Whi5 data and for the total G1 data are similar (Figure 3.6). Thus
G1 size control is restricted to T1, the period of Whi5 nuclear residence. T2, the part of
G1 after Whi5 exit, is independent of cell size, and similar in mothers and daughters
(Bean et al., 2006) (Table 3.3).

These observations are robust to changes in nutrient conditions: growth of cells in
glycerol/ethanol instead of glucose, resulting in slow growth and generation of very small
newborn daughter cells, gave quantitatively similar results (Figures 3.6, 3.10 d). As for
G1 duration, also for Whi5 nuclear residence times the data for glycerol-ethanol-grown
daughters fell on the same quantitative line as that already established for glucose-grown
cells. This implies a growth-rate-independent size control mechanism operating over a
wide range of daughter cell sizes (Figure 3.6). The combined data sets for
glycerol/ethanol and glucose strongly supported a two-slope model Whi5 nuclear
residence times (see Figure 3.6 and Table 3.5).
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Figure 3.10 The correlation between cell size and the regulation of Whi5 nuclear
residence supports decomposition of Start into a size control module and an
independent timing module. a) αTG1 vs. ln(Mbirth) as in Figure 3.5f; wt data (solid blue
dots) were supplemented with data from unusually small wild-type haploid daughters
(open green circles); b) αT1 vs. ln(Mbirth); c) binned data from Figure 3.10b (green points,
black line) and Figure 3.5e (blue points, red line); d) Binned data for αT1 (green points,
black line) and αTG1 (blue points, red line) vs. ln(Mbirth) for cells grown in
glycerol/ethanol (see also Figure 3.6); e) αT1 and αTG1 vs. ln(Mbirth) for 6xCLN3 cells; f)
αTG1 vs. ln(Mbirth) for whi5 cells.
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Even in glycerol-ethanol, mother cells exhibit no evidence of size control over Whi5
nuclear exit.

Efficient size control, indicated by the steep slope for small wild-type daughters, is
essentially eliminated by increase in CLN3 gene dosage or deletion of WHI5 (Figures
3.10 e, f). In contrast, increasing CLN2 gene dosage does not alter size control and the
regulation of T1 (see Figure 3.11)

CLN3 and CLN2 copy number had differential effects on G1 variability in mothers and
daughters (Figure 3.3). The two-step model explains this, since increase in CLN3 copy
number should only affect the first step, which is slow in daughters but extremely rapid in
mothers. Since in mothers, G1 is temporally dominated by the second step, mother cell
G1 variability is more sensitive to changes in CLN2 copy number (Figure 3.3).
Consistent with this idea and with independence of the two steps, combining 6X CLN3
together with
6X CLN2 in one haploid genome resulted in low G1 variability in both mothers and
daughters (Table 3.7, Figure 3.3).

Thus we decompose G1 into two independent steps separated by Whi5 nuclear exit: a
size sensing module and a size-independent timing module. The first step is dependent
on both Cln3 and cell size, and the second step is dependent on Cln2, but independent of
cell size and Cln3 (Figure 3.12). Temporal variability in the first step is due to the
natural
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Figure 3.11 CLN2 gene dosage does not affect the duration of the period from
cytokinesis to Whi5 nuclear exit. Correlation between the duration of the period from
cytokinesis to Whi5 nuclear exit, T1, scaled with growth rate, α, and the logarithm of cell
size at birth for wt (blue points and lines) and 6xCLN2 strains (red points and lines). The
same break-point deduced for wt cells was used for the two-slope model of 6xCLN2 cells.

Figure 3.12 Start regulatory dynamics is composed of two independent modules. A
model decomposing Start into a size control module and an independent timing module
unaffected by cell size.
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variability in cell size at birth coupled to size control, as well as molecular noise, possibly
due to variability in CLN3 expression. The duration of the second step is cell-size
independent; its variability is affected by the expression of the G1 cyclin CLN2, one of
the primary final effectors of Start (Cross, 1995; Dirick et al., 1995; Tyers et al., 1993).

Positive feedback sharpens the transition between the two modules of Start and
ensures coherent cell cycle entry. The modular dynamics of Start suggest that the
transition between the two modules could be controlled by a switch-like molecular
network. In recent work led by Jan Skotheim, in which I collaborated, we have shown
that the switch-like properties of Start are the result of positive feedback of Cln1 and
Cln2 on their own transcription (Skotheim et al., 2008).
In order to investigate if Cln1- and Cln2-dependent positive feedback operated through
Whi5, we developed a quantitative assay for nuclear levels of Whi5–GFP by marking the
nucleus with HTB2-mCherry (histone H2B) and measuring the difference between
nuclear and cytoplasmic GFP fluorescence intensity (Figure 3.13a-c) (Skotheim et al.,
2008). Whi5 entered the nucleus rapidly in both wild-type and cln1 cln2 cells. In wildtype cells, Whi5 also exited very rapidly; in cln1 cln2 cells, Whi5 exited much more
slowly (Figure 3.13d-g, i) consistent with biochemical data showing that Whi5 remains
on the CLN2 promoter longer in cln1 cln2 than in wild-type cells (de Bruin et al., 2004).
Because Whi5–GFP remained nuclear in cln1 cln2 cln3 cells (Figure 3.13h), the slow
Whi5 exit in cln1 cln2 cells is Cln3-dependent (this also excludes photobleaching
artifacts). Thus, Cln3 initiates the slow exit of Whi5 from the nucleus, whereas Cln1 and
Cln2 rapidly remove the remainder. It can also be shown that rapid Whi5 exit coincided
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with the time of activation of CLN1 and CLN2 transcription and initiation of Cln1- and
Cln2-dependent positive feedback (Skotheim et al 2008). Once feedback is initiated, the
rapidly accumulating Cln1 and Cln2 probably dominate cellular Cln-kinase activity, and
Cln3, the rate-limiting upstream activator, is probably rendered unimportant after this
point. Thus, positive feedback sharpens the transition between the size control module
and the timing module, with the transition marked by Whi5 nuclear exit.
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Figure 3.13 Cln1 and Cln2 are required for rapid phosphorylation and inactivation of the ratelimiting inhibitor Whi5. a)–c), Combined phase and fluorescence images showing Whi5–GFP and Htb2–
mCherry (to mark the nucleus) fusion proteins for wild-type (a), cln1 cln2 (b) and cln1 cln2 cln3 (c) cells.
The difference between nuclear and non-nuclear fluorescence intensity was used to quantify nuclear Whi5
by automated image analysis. d)–h), Nuclear Whi5–GFP fluorescence. In comparison to wild-type cells
(d, e), cln1 cln2 cells display delayed and less sharp Whi5 nuclear exit (f, g). Whi5 remains nuclear in
cln1 cln2 cln3 cells (h). i) The percentage of cells in which Whi5 has left the nucleus (defined as attaining
half the maximum amount) versus the time from Whi5 nuclear entry. (Figure courtesy of Jan Skotheim).
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Chapter 4: Asymmetric cell fates and regulation of Start.
Cell division in budding yeast is asymmetric yielding a bigger mother cell and a smaller
daughter cell (Hartwell and Unger, 1977). Regulation of gene expression is also
asymmetric in mother and daughter cells as result of the daughter-specific localization of
transcription factors Ace2 and Ash1 (see Chapter1). We have shown in the previous
Chapter that cell size plays a crucial role in the regulation of Start with small daughter
cells delaying cell cycle commitment and mother cells progressing quickly through Start.
In this Chapter, we analyze the interaction between daughter-specific transcriptional
programs, G1 cell size control, and irreversible commitment to the cell cycle at Start.

Differential regulation of Start in mothers and daughters is dependent on Ace2 and
Ash1. We have shown in Chapter 3 how size control is restricted to T1, the period of
nuclear residence of transcriptional repressor Whi5, and that this interval accounts for the
longer duration of G1 in daughter cells. The different duration of the period T1 in
mothers and daughters could in principle be solely a consequence of size control
imposing a delay in the smaller daughter cells (Hartwell and Unger, 1977). To
investigate if cell size is solely responsible for the longer T1 of daughter cells, we
analyzed the correlation between αT1 and ln(Mbirth) specifically for the sub-population of
mothers and daughters with similar sizes at birth. This comparison demonstrates an
increase in αT1 in daughters compared to mothers of similar size (Figure 4.1b, 4.1c; Table
4.1). This delay is most readily detectable in glycerol-ethanol medium, in which cell
growth is much slower than in glucose medium; slower growth results in smaller
daughter size at the time of cell
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Figure 4.1 Differential regulation of Start is dependent on Ace2 and Ash1. a)-h)
Correlation between αT1 and ln (Mbirth) for cells grown in glucose or glycerol/ethanol. (a,
b) wt, (c, d) ace2, (e, f) ash1, (g, h) ace2 ash1. Bars in a) and b) illustrate the region of
size overlap in the case of wt cells. Red dots: mothers, blue dots: daughters. Black
semicircles: Ace2, yellow semicircles: Ash1.
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division (Hartwell and Unger, 1977) (Figure 4.1c). In glycerol-ethanol, in the region of
size overlap daughters exhibit clear size control (slope ~-0.8) while mothers exhibit
essentially none (slope ~0). A daughter delay independent of cell size in G1 was
previously observed in cells grown in low concentration of hydroxyurea that results in
mother and daughter cell size at birth significantly larger than that of wt cells (Lord and
Wheals, 1983). Our observations confirm and extend this result in unperturbed cycling
cells, relying solely on natural variation in cell size at birth.

Because Ace2 and Ash1 are specifically inherited by daughters, and because previous
results implicated Ace2 in a daughter delay (Laabs et al., 2003), we analyzed the
correlation between αT1 and ln(Mbirth) in ace2 and ash1 single and double mutants.
Deletion of these transcription factors greatly reduces the daughter-specific delay
compared to mothers of similar size, and results in altered size control properties of
daughter cells (Figures 4.1h, 4.1i and Table 4.1). Only very small ace2 ash1 daughters
present in cultures grown in glycerol/ethanol display efficient size control (Figure 4.1i).
According to this analysis, the effect of deleting ACE2 and ASH1 is to shift efficient size
control to smaller cell size.

Single mutants (ace2 ASH1 and ACE2 ash1) display a phenotype similar to but less
extreme than ace2 ash1 double mutants (Figures 4.1d-4.1g, Table 4.1). Ace2 contributes
to transcriptional activation of ASH1 (McBride et al., 1999), so some but not all of the
effects of ACE2 deletion may be a consequence of reduced ASH1 expression.
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Daughter-mother

wt

ash1

ace2

ace2 ash1

8 ± 1 min

5 ± 1 min

2 ± 3 min

2 ± 3 min

(0.03)

(0.06)

(0.06)

47 ± 8 min

16 ± 13 min

18 ± 9 min

(<10-3)

(<10-5)

(<10-7)

wt

ASH1*

ACE2*

ASH1* ACE2*

8 ± 1 min

5 ± 1 min

1.3 ± 0.9 min

1.3 ± 0.9 min

(0.03)

(<10-5)

(<10-5)

19 ± 7 min

46 ± 12 min

5± 7 min

(<10-8)

(0.006)

(<10-12)

wt

cln3

ADH1p-CLN3 nxCDC28p-CLN3

8 ± 1 min

2 ± 1 min

N/A

delay in glucose
Daughter-mother

87 ± 9 min

delay in gly/eth

Daughter-mother
delay in glucose
Daughter-mother

87 ± 9 min

delay in gly/eth

Daughter-mother

(<10-4)

delay in glucose
Daughter-mother

87 ± 9 min

delay in gly/eth

3 ± 1 min
(<10-3)

9 ± 13 min

22 ± 13 min

36 ± 14 min

(<10-6)

(<10-4)

(0.003)

Table 4.1 Average daughter delay in new-born cells of the same size. Data from the
correlation of αT1 and ln(Mbirth) were divided in small bins and the daughter delays
computed for every bin were averaged. In parenthesis is the p-value computed by t-test
for the null hypothesis that the delay of daughters compared to mothers is the same for
the mutants as for wild-type.
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In strains with ACE2 and/or ASH1 deleted, little effect on mother cell size control is
expected or observed, since mother cells naturally lack Ace2 and Ash1 due to differential
segregation of the factors at cell division (see Chapter 1). ace2 ash1 daughters exhibit
efficient size control only when born at a size that mothers almost always exceed due to
the budding mode of growth (Hartwell and Unger, 1977) (Figures 4.1b, 4.1c).

To test whether Ace2 or Ash1 have the capacity to affect size control in mothers, we
employed mutations resulting in symmetrical inheritance of the factors to mothers and
daughters. We used an Ace2 mutant, ACE2G128E (indicated as ‘ACE2*’ from here on),
which accumulates in both mother and daughter nuclei, activating Ace2-dependent
transcription in both (Colman-Lerner et al., 2001; Racki et al., 2000), and an ASH1
mutant, ASH1-MUT (‘ASH1*’) in which mutation of localization elements in ASH1
mRNA results in accumulation of Ash1 in both mother and daughter nuclei (Chartrand et
al., 2002). Symmetric localization of both factors greatly reduces the difference in T1
length in mothers and daughters born at similar sizes (Figures 4.2g, 4.2h, Table 4.1).
Strikingly, ACE2* ASH1* mothers exhibit efficient size control when born small (such
mother cells are observed in significant numbers in glycerol-ethanol culture) (Figure
4.2h). Strains in which only Ash1 or Ace2 is symmetrically localized show intermediate
phenotypes (Figures 4.2c-4.2f, Table 4.1), suggesting again that both transcription factors
contribute to the daughter-specific delay in partially independent ways. Interestingly,
symmetric localization of Ace2 but not Ash1 drives almost completely symmetric control
of Start in glucose medium, while the opposite is true in glycerol/ethanol (Table 4.1).
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Figure 4.2 Symmetric localization of Ace2 and Ash1 result in symmetric control of
Start in mothers and daughters. a)-h) Correlation between αT1 and ln (Mbirth) for cells
grown in glucose or glycerol/ethanol. (a, b) wt, (c, d) ACE2*, (e, f) ASH1*, (g, h) ACE2*
ASH1*. Red dots: mothers, blue dots: daughters. Black semicircles: Ace2, yellow
semicircles: Ash1.
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ACE2* and ASH1* had little effect on size control properties of daughter cells, as
expected since these factors are already present in wild-type daughters.

Altogether, these results show that Ace2 and Ash1 define daughter-specific programs
that set the size range at which daughters display efficient size control to a higher value
than that of mothers. Ace2 and Ash1 appear to be necessary and sufficient for this
resetting.

This idea leads to the prediction that ACE2* ASH1* mothers and daughters should be
‘pseudo-daughters’ with respect to size control, while ace2 ash1 mothers and daughters
should be ‘pseudo-mothers’. To test this, we combined data for mothers and pseudomothers, and daughters and pseudo-daughters, in rich and poor medium. Remarkably,
these combined data sets collapsed onto one plot for all mother-like cells and a different
plot for all daughter-like cells (Figures 4.3a, 4.3b, 4.4, 4.5). The noise about the lines in
these plots (size-independent variation) is of a magnitude consistent with previous results
(see Chapter 3). Further analysis showed that the daughter-like plot could be transformed
to the mother-like plot simply by shifting the curve 0.2 units of ln(Mbirth) (Figures 4.3c,
4.3d). This implies that cells containing Ace2 and Ash1 interpret a given cell size as
being effectively ~20% larger than the same size in cells lacking Ace2 and Ash1, with
respect to commitment to Start. This size interpretation is independent of actual
mother/daughter status.
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Figure 4.3 Daughter-specific localization of Ace2 and Ash1 result in asymmetric
control of Start. a) Correlation between αT1 and ln (Mbirth) for mothers and “pseudomothers” grown in glucose or glycerol/ethanol. b) Correlation between αT1 and ln
(Mbirth) for daughters and “pseudo-daughters” grown in glucose or glycerol/ethanol. c)
Correlation between αT1 and ln (Mbirth) mother-like and daughter-like cells. The graphs
are obtained by binning the data shown in a) and b). Error bars are standard errors of the
mean. d) Probability of Whi5 nuclear exit as a function of ln(M) from data in c).
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Figure 4.4 Start control is similar in mothers and “pseudo-mothers”. Plot of T1 vs.
ln(Mbirth) for the average ‘mother-like’ (red dots and error-bars, see Figure 4.3) compared
to mothers and “pseudo-mothers” (black dots).
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Figure 4.5 Start control is similar in daughters and “pseudo-daughters”. Plot of T1
vs. ln(Mbirth) for the average ‘daughter-like’ (blue dots and error-bars, see Figure 4.3)
compared to daughters and “pseudo-daughters” (black dots).
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Laabs et al. (2003) claimed symmetrical G1 durations for ace2 mothers and daughters,
and for ACE2* mothers and daughters, independent of cell size. It is important to note a
critical distinction between their results and ours. We find that ace2 ash1 mothers and
daughters, and ACE2* ASH1* mothers and daughters, are symmetrical with respect to T1
duration in cells of a given size. This is independent of whether a given individual
mother-daughter pair will exhibit equal T1 durations, as claimed for time to budding by
Laabs et al. (2003). Indeed, in many individual mother-daughter pairs of these mutant
genotypes (especially in glycerol/ethanol medium), the daughter does exhibit a longer T1
than the mother; we attribute this to the fact that most mothers are bigger than the
daughters they produce (Hartwell and Unger, 1977) (Figures 4.1b, 4.1c). Laabs et al.
(2003) compared times of second budding in mother-daughter pairs with 10 min
resolution, following only the first bud emergence after plating. We time the duration of
Whi5 nuclear residence, that accounts for the mother-daughter differences in G1 duration
(Bean et al., 2006) rather than budding, eliminating significant variability in timing of
this later step. We also have a precise time of origin for cell birth (cytokinesis occurs 6
min after Whi5-GFP nuclear entry (Figure 3.4) (Di Talia et al., 2007)allowing
comparison of T1 durations in unrelated mothers and daughters. We use 3-minute
resolution rather than 10-minute resolution. Finally, we follow multiple cell cycles in
unperturbed exponentially growing microcolonies rather than just the first bud emergence
after plating, which avoids artifacts specifically due to the physical manipulations
involved in preparing and plating the cells for time-lapse microscopy.
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Genome-wide analysis of Ace2 and Ash1 targets. To determine the transcriptional
target(s) through which Ace2 and Ash1 modulate size control in daughters, we performed
microarray analysis of synchronized cell populations, comparing cells in which Ace2 and
Ash1 are deleted to cells in which they localize symmetrically to both mother and
daughter nuclei. Doing the comparisons in this way, rather than simply comparing wildtype to mutants, increases sensitivity of the analysis, since wild-type cultures always
contain a mixture of mothers and daughters, reducing the detectable effects of
manipulation of daughter-specific transcription factors. Our approach thus relies on three
comparisons: ace2 ash1 vs. ACE2* ASH1*, ace2 vs. ACE2*, and ash1 vs. ASH1* cells.

We also compared swi5, ace2 and swi5 ace2 and wild-type in order to obtain insight
into the set of genes regulated by one or both of these factors. Swi5 and Ace2 are closely
related transcription factors that recognize the same DNA sequence and share many
target genes and (Dohrmann et al., 1992; Voth et al., 2007). The best-characterized Ash1
target, HO, is also a Swi5 target and its regulation by Swi5 and Ash1 is required for
mother-daughter asymmetry in mating type switching (Bobola et al., 1996; Sil and
Herskowitz, 1996).

To synchronize cells during the critical M/G1 interval, we used strains expressing
Cdc20 under the control of an inducible promoter (the truncated GAL1 promoter, GALL
(Mumberg et al., 1994)). Cells were arrested in metaphase by depletion of Cdc20 in
glucose medium, and released from the arrest by transfer to galactose medium to reinduce
Cdc20. mRNA was extracted every 5 minutes, and hybridized to microarrays. This
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synchronization procedure provides excellent synchrony in the M/G1 interval (anaphase,
cell division, and early G1) immediately following release, which is the time of nuclear
localization and transcriptional activity of Ace2, Swi5 and Ash1 (Figure 4.6a, (Spellman
et al., 1998; Voth et al., 2007)).

About 15 minutes after release, cells of all genotypes complete anaphase and degrade
the mitotic cyclin Clb2 (see Figure 4.6a). Subsequently, cells separate and rebud (Figure
4.6a). Both Swi5 and Ace2 enter the nucleus at about the time of anaphase (Figure 4.6a).
On average, Swi5 nuclear entry precedes Ace2 nuclear entry by 2-3 minutes (Swi5
nuclear entry: 11.4±0.4 min before cytokinesis, Ace2 nuclear entry: 8.4±0.2 min before
cytokinesis). A slightly longer (10 min) Ace2 delay relative to Swi5 entry was recently
reported (Sbia et al., 2008). Swi5 is rapidly degraded and disappears 4 minutes before
cytokinesis (Tebb et al., 1993), (Figure 4.6a). Ace2 remains in the nucleus for a longer
period and is present in the daughter nucleus during G1 (for about 15 minutes) but
quickly excluded from the mother nucleus (Colman-Lerner et al., 2001) (Figure 4.6a).
Ash1 protein begins to accumulate a few minutes after Swi5 and Ace2 nuclear entry, and
localizes to the nucleus slightly before cytokinesis, remaining until about the time of
budding (Bobola et al., 1996), (Figure 4.6a).

The microarrays for wild-type cells show well defined M/G1 and G1/S clusters consistent
with previous results (Spellman et al., 1998) (Figure 4.6b). Furthermore, wellcharacterized Ace2 and Ash1 targets, such as CTS1 and HO, behave as expected upon
transcription factor deletion or mislocalization (see Figure 4.6c). Cell-cycle-regulated
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Figure 4.6 Genome-wide analyses of Ace2 and Ash1 targets. a) Analysis of cell cycle
synchronization and nuclear localization of Ace2, Swi5 and Ash1 in a cdc20 blockrelease experiment. Top panel shows the percentage of mononucleate cells, large budded
cells and cells that have rebudded. The middle panel shows the levels of mitotic cyclin
Clb2. The lower panel shows the dynamics of nuclear localization of fluorescently
tagged Ace2, Swi5 and Ash1. b) Expression data from the M/G1 and G1/S cell cycle
regulated cluster of genes. c) The regulation of CTS1 (Ace2 target), HO (Ash1 target)
and SWI5 (Fkh1,2 Mcm1 target) expression from the microarray series, as well as data
obtained by point-by-point subtraction of the arrays (ACE2* - ace2, ASH1* - ash1,
ACE2* ASH1* - ace2 ash1) .
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genes that are unaffected by the two transcription factors behave very similarly in all
arrays (Figure 4.6c). Notice that the time of anaphase, which varies slightly between
experiments, was used as the zero time to make the comparisons more accurate.

The high reproducibility of these microarray data allows us to do a time-point by timepoint subtraction of the deletion mutant data from the mislocalization mutant data. This
subtraction cancels out most of the cell-cycle-regulated changes in gene expression that
are independent of Ace2 and/or Ash1, allowing the hierarchical clustering algorithm
(Eisen et al., 1998) to efficiently detect changes that are specifically due to these
transcription factors (see Figure 4.6c).

Clustering analysis of the subtracted data reveals a clear Ace2-dependent cluster
composed of 12 genes: PSA1, FAA3, EGT2 (EGT2 and FAA3 expression is slightly
dependent on Swi5), DSE4, AMN1, PRY3, BUD9, SCW11, DSE1, DSE2, CTS1 and
SUN4. Only two genes, HO and PST1, displayed strong changes in expression upon
deletion or mislocalization of Ash1.

None of the genes whose expression is strongly Ace2- or Ash1-dependent is a known
cell cycle regulator, suggesting that their misregulation is not likely to be responsible for
cell-type-specific regulation of Start. We therefore performed a statistical analysis to
obtain a list of genes regulated by both Ace2 and Ash1. We imposed an ‘AND’ logical
condition that co-regulated targets should be detected as a differential signals in the
subtracted ace2 vs. ACE2*, ash1 vs. ASH1* and ace2 ash1 vs. ACE2* ASH1*
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comparisons. Additionally, we imposed a temporal requirement that the observed
Ace2/Ash1-dependent changes in expression be observed only at times when these
factors have accumulated in wild-type nuclei (Figure 4.6a). This criterion excludes genes
whose changes in expression are long-term, indirect consequences of mutation of Ace2 or
Ash1. Using a p-value cutoff sufficient for an expected false positive rate of less than
one gene over the whole genome, we identified only 5 Ace2/Ash1 shared targets: CLN3,
HSP150, MET6, YRF1-1, and YRF1-5 (see Table 4.2 for details).

A direct interaction between Ace2 or Ash1 and the promoter of 3 of these genes (Ace2:
CLN3 and HSP150, Ash1: YRF1-1) has been previously observed in ChIP-chip
experiments (Harbison et al., 2004; Simon et al., 2001), supporting the validity of our
analysis. YRF1 is a gene repeated 7 times in the yeast genome. While not perfectly
conserved, the promoter regions of these 7 genes are very similar. The promoter region
of YRF1-5 is basically identical to that of YRF1-1 (identical from -854 to +1), supporting
its presence in our list. Ace2 has also been shown to bind to the YRF1-2 promoter
(Harbison et al., 2004).

Prominent in the list of genes affected by both Ace2 and Ash1 is the G1 cyclin, CLN3, a
rate-limiting activator of the Start transition. This suggested the hypothesis that
differential regulation of Start may be a consequence of differential regulation of CLN3.
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Gene name

p-value in ACE2*-

p-value in ASH1*-

p-value in ASH1* ACE2*-

ace2 dataset

ash1 dataset

ash1 ace2 dataset (see below)

-4

CLN3

0.02

4*10

0.04

HSP150

0.001

0.01

0.03

MET6

4*10-6

0.01

0.04

YRF1-1

0.02

2*10-4

0.04

YRF1-5

0.0068

3*10-5

0.03

Table 4.2 Analysis of Ace2 and Ash1 shared targets. We report the p-values that the
expression of listed genes is not affected by Ace2 and Ash1. For unknown experimental
reasons the error bars on the ASH1* ACE2*-ash1 ace2 dataset were on average two times
bigger than the error bars on the ACE2*-ace2 and ASH1*-ash1 datasets.

Ace2 and Ash1 regulate the expression of G1 cyclin CLN3. CLN3 expression in
M/G1 is from 1.5 to 2.5 fold higher in ash1 ace2 cells (pseudo-mothers) than in ASH1*
ACE2* cells (pseudo-daughters) (Figure 4.7a). While this change is small, CLN3 is a
highly dosage-sensitive activator of Start, with effects on cell size control detectable upon
2-fold changes up or down in gene dosage (McInerny et al., 1997; Nash et al., 1988).
Therefore, this differential regulation could explain different T1 times in wild-type
mothers and daughters of similar size, as Cln3 controls T1 (see Chapter 3). Differential
regulation of CLN3 was also observed in experiments with synchronized population of
cells (MacKay et al., 2001; McInerny et al., 1997). In populations of cells containing
both mothers and daughters, CLN3 expression peaks at the M/G1 boundary (McInerny et
al., 1997), while in populations of size-selected daughters CLN3 expression peaks later in
G1 (MacKay et al., 2001), consistent with our conclusion that CLN3 expression in M/G1
is higher in mothers than in daughters. M/G1 expression of CLN3 is driven by Mcm1
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through early cell-cycle box (ECB) elements (McInerny et al., 1997); our results suggest
that Ace2 and Ash1 antagonize this activation.

Analysis of ace2 vs. ACE2* arrays (Figure 4.7b) shows that CLN3 behaves similarly to
a cluster of nine strongly Swi5/Ace2-dependent genes (YPL158C, PCL9, CYK3, NIS1,
DSE3, SIC1, ASH1, PIR1, EXG1). Expression of these genes in ACE2* cells is lower
than expression in ace2 at 5 minutes after anaphase but similar at 10 minutes and higher
from 15 minutes to 25 minutes (Figure 4.7e). This rather specific pattern is significantly
different from a pattern assuming no regulation by Ace2 (p<10-16). CLN3 expression
depends on Ace2 similarly to these other Swi5/Ace2 targets (p=0.3, Figure 4.7e); a model
assuming that CLN3 is not affected by Ace2 can be excluded (p<0.03, Figure 4.7f).

Ace2-dependent repression of CLN3 was suggested previously based on analysis of a
CLN3pr-GFP fusion (Laabs et al., 2003). Our data agree with this, and further suggest
that the repression may be limited to a brief period after anaphase.

Microarrays of swi5 vs. wild-type cells indicate that Swi5 activates CLN3 expression,
which is reduced by two fold in swi5 cells (Figure 4.7d). Thus CLN3 and a class of
Ace2/Swi5 dependent genes follow a pattern consistent with early repression and late
activation by Ace2, and with early activation by Swi5, likely acting in concert with ECB
regulation (McInerny et al., 1997). We do not know the reason for this complex pattern;
we speculate that Ace2 may be an intrinsically poorer activator than Swi5, but activates
for a longer period due to its longer lifetime and nuclear residence. Swi5 disappears from
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Figure 4.7 Ace2, Swi5 and Ash1 regulate the expression of the G1 cyclin CLN3.
CLN3 expression in ACE2* ASH1* vs. ace2 ash1 (a), ACE2* vs. ace2 (b), ASH1* vs.
ash1 (c).

d) Expression of Ace2 and Swi5-dependent cluster of genes.

e) CLN3

expression compared with the average expression of 9 strong Ace2 and Swi5-dependent
genes from the dataset obtained by subtracting the ACE2* data from the ace2 data. f)
CLN3 expression compared with the average expression of the whole genome from the
same dataset (i.e. ace2 - ACE2*). Chromatin immunoprecipitation (ChIP) analysis of the
interaction between Swi5 (g), Ace2 (h) and the CLN3 promoter. Following cross-linking
and immunoprecipitation, DNA was amplified by PCR. Amplification of a region of the
ORF of DYN1 was used as negative control, while regions of the SIC1 and CTS1
promoters were used as positive controls for Swi5, Ace2 respectively. All the strains
were TAP-tagged (NC=negative control from an untagged strain, WCE= whole cell
extract). i) Representation of the Ace2/Swi5 and Ash1 putative binding sites on the
CLN3 promoter.
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both mother and daughter nuclei a few minutes after anaphase, while Ace2 persists in
daughter nuclei for about 20 min longer (Figure 4.6a). Competition between Ace2 and
Swi5 for the same binding site (Dohrmann et al., 1992) could then contribute to the
differential expression observed in these arrays.

Microarray analysis for ash1 and ASH1* shows that CLN3 expression is repressed about
two fold by Ash1 during the period from 10 minutes to 25 minutes after anaphase (Figure
4.7c). During this interval Ash1 is present in the nucleus (Figure 4.6a), suggesting that it
could be a direct repressor of CLN3 expression.

A substantial class of Swi5 and Ace2/Swi5 targets have higher expression in the
absence of Ash1 (3 Swi5-specific genes: CDC6, CHS1 and YLR194C and 29 genes coactivated by Ace2 and Swi5: PTI1, SIW14, YGR016W, NCB2, MRS1, PCL2, KAR1,
YPL088W, PIR1, PST1, CLN3, YNL046W, YLR049C, YBR071W, YAL053W, YLR414C,
KEL1, PSK2, YPL158C, PCL9, CYK3, NIS1, DSE3, SIC1, ASH1, PIR1, EXG1, HDA1
and GAT1). The absolute repression of Swi5-dependent HO expression by Ash1 in
daughter cells may thus be an enhancement of a common pattern of co-regulation.

Our data suggest that Ace2 and Ash1 may cooperate to repress CLN3 expression in
daughters. Consistently, activation of the G1/S regulon controlled by Cln3 is delayed
and/or happens at larger cell size in cdc20-synchronized cells containing these factors
(see Figure 4.9).
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Figure 4.8 Ash1 is a modulator of Swi5-dependent expression. Average expression
for Ace2/Swi5 and Swi5 targets (32 genes) in response to Ash1 (data were obtained by
subtracting the ASH1* dataset from ash1 dataset). This graph shows that Ash1 weakly
represses the expression of many Ace2/Swi5 and Swi5 targets in daughter cells.

Ace2 and Swi5 may be direct transcriptional regulators of CLN3. We performed
chromatin immunoprecipitation (ChIP) experiments in synchronized cell populations, to
test if Ace2, Swi5 and Ash1 bind to the CLN3 promoter. Genome-wide localization data
in asynchronous cell populations suggested binding of these factors to the CLN3
promoter, but are statistically insufficient to definitively prove the association (Harbison
et al., 2004; Simon et al., 2001). We used synchronized cell populations to provide
dynamical information on the possible binding of Ace2, Swi5 and Ash1 to the CLN3
promoter, providing a higher signal-to-noise ratio than can be obtained from
asynchronous cells.
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Figure 4.9 Activation of SBF and MBF is delayed by Ace2 and Ash1. Average
expression of 20 SBF/MBF targets in a) ace2 and ACE2*, b) ash1 and ASH1*, c) ace2
ash1 and ACE2* ASH1* cells. Distribution of cell size at birth after release from the
cdc20 arrest for d) ace2 ash1 and e) ACE2* ASH1* cells.

Swi5 and Ace2 bound to regions in the CLN3 promoter around the time of anaphase,
coincident with their nuclear entry (Figures 4.7g, 4.7h). Swi5 is on the CLN3 promoter
for only a few minutes (Figure 4.7g), while Ace2 is on the CLN3 promoter for about
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20 minutes (Figure 4.7h), also consistent with the time of Swi5 and Ace2 nuclear
localization (Figure 4.6a). Thus, Ace2 and Swi5 might regulate CLN3 transcription by
directly binding to multiple Ace2/Swi5 sites in the CLN3 promoter (Figures 4.7g-4.7i).

We were unable to obtain reliable data on cell-cycle-specific Ash1 binding to either the
CLN3 promoter or the positive control HO promoter; therefore, we cannot assess if Ash1
binds directly to the CLN3 promoter by this method.

Mutations of Ace2/Swi5 and Ash1 binding sites on the CLN3 promoter reduce the
asymmetry of Start regulation. We identified three candidate Ace2/Swi5 sites
(GCTGG) (Harbison et al., 2004) in the CLN3 promoter. We also identified two possible
variant sites (GCTGA); such sites are over-represented in Ace2 and Swi5 targets (data
not shown). There are eight candidate Ash1-binding sites (YTGAT) (Maxon and
Herskowitz, 2001) in the CLN3 promoter. We mutated the Ace2/Swi5 and/or the Ash1
putative binding sites in the CLN3 promoter by exact gene replacement (see Chapter 2).
Plots of αT1 vs. ln(Mbirth) show that these mutations significantly reduce the T1 delay in
daughters compared to similarly sized mothers (Figure 4.10). This effect is especially
notable in cells grown in glycerol-ethanol. Although these promoter mutations have
strong effects, they are less potent than deletion of ACE2 and ASH1 (compare Figure 4.1
with Figure 4.10). This could reflect the presence of additional non-consensus Ace2 or
Ash1 sites in the promoter. Additionally, the comparison between mutating Ace2 sites
and deleting ACE2 is not exact because removing Ace2 sites perforce also removes Swi5
sites. Ace2 and Ash1 could also have other indirect effects on CLN3 expression, perhaps
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Figure 4.10 Deletion of the Ace2/Swi5 and Ash1 binding sites on the CLN3 promoter
reduces the asymmetrical regulation of Start. Correlation between αT1 and ln (Mbirth)
for cells grown in glucose or glycerol/ethanol in mutants lacking the Ace2/Swi5 and/or
Ash1 sites on the CLN3 promoter. (a, b) wt, (c, d) Ace2/Swi5 sites deleted, (e, f) Ash1
sites deleted, (g, h) Ace2/Swi5 and Ash1 sites deleted. Red dots: mothers, blue dots:
daughters.
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working through the ‘DDE’ sites in the CLN3 promoter, proposed by Laabs et al. (2003)
as indirect Ace2 targets. Simultaneous deletion of Ace2 and Ash1 sites slightly enhanced
the phenotype of deletion only of one or the other.

Still, the promoter mutants lacking Ace2/Swi5 sites and/or Ash1 sites strongly reduce
asymmetry of control of Start by cell size in mothers and daughters, supporting the idea
that Ace2/Ash1 directly repress CLN3 expression in M/G1, accounting for a significant
part of the regulation of G1 length by these transcription factors.

Asymmetric regulation of CLN3 is required for asymmetric regulation of Start.
We analyzed the correlation between αT1 and ln(Mbirth) (see above) in cln3 cells, and in
cln3 cells expressing CLN3 from constitutively active promoters. It is important for this
analysis that the constitutive promoters provide expression levels of Cln3 similar to those
in wild-type cells, and that the promoter-CLN3 fusions complement the large-cell
phenotype of cln3 mutants, without ‘overshoot’ to a small-cell phenotype (Cross, 1988,
1989; Nash et al., 1988). We screened a number of different constitutive promoters of
different strengths (N. Buchler, pers. comm.) for these properties, examining both cell
size and Cln3 protein levels using myc-tagged Cln3, compared to wild-type (including a
minor correction for cell cycle regulation of CLN3 expression (Table 4.3) (McInerny et
al., 1997)).

The ACT1 and the ADH1 promoters result in over-expression of Cln3 and in a small size
phenotype for cells grown in glucose-containing media (Table 4.3). Expression of Cln3
from the CDC28 promoter is weaker than expression from the CLN3 promoter and results
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in cell sizes bigger than wild-type and only slightly smaller than that of cln3 cells (Table
4.3). Integration into the yeast genome of 6 copies of the CDC28pr-CLN3 construct
results in a cell size distribution similar to that of wt cells. We also analyzed the effects
of these constructs in glycerol-ethanol medium.

Four tandemly integrated copies of

CDC28pr-CLN3 results in an overall cell size distribution similar to that of wt cells in
glycerol-ethanol. As a result of decreased ADH1 expression in non-fermentable media
(Denis et al., 1983), the ADH1 promoter provides Cln3 levels similar to endogenous
levels in glycerol-ethanol, resulting in a cell size distribution slightly (~ 10%) larger than
wild-type (Table 4.3).

wt

cln3

Cln3 levels in D

1

Cln3 levels in g/e
cell size in D (fl)

0

CDC28prCLN3
0.4-0.6

ACT1prCLN3
5-7

ADH1prCLN3
8-10

1

0

0.2-0.5

8-10

1.5-2.0

56

92

84

45

45

cell size in g/e (fl) 47

88

60

41

51

Table 4.3 Levels of Cln3 expression and average cell size for asynchronous cell
populations expressing CLN3 from various constitutive promoters. The expression
of CLN3 is cell cycle regulated with a peak in expression at M/G1 characterized by a
peak to through ratio of order 3 ((McInerny et al., 1997), see Figure 4.7) . This suggests
that constructs whose average expression is larger than 3 times the average expression of
Cln3 are likely to be overexpressors.

Measurements of Cln3 protein levels show that Cln3 overexpressors were smaller than
wt, and underexpressors larger (Table 4.3). Based on results with a single copy of
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CDC28pr-CLN3-myc, 4-6 copies of CDC28pr-CLN3 would be expected to produce
approximately wt levels of Cln3 in M/G1, consistent with the observed cell size
distributions (Table 4.3).

We therefore used strains containing 6xCDC28pr-CLN3 in glucose medium, and strains
containing 4xCDC28pr-CLN3 or ADH1pr-CLN3 in glycerol-ethanol medium to provide
approximately endogenous levels of expression without mother-daughter asymmetry. In
6xCDC28pr-CLN3 cells the daughter-specific delay is almost entirely abolished (Figures
4.11c, 4.11e and Table 4.3). Similarly, in 4xCDC28pr-CLN3 and ADH1pr-CLN3 cells
grown in glycerol/ethanol, the daughter-specific delay is almost entirely abolished, and
small mothers and daughter have similar size control properties (Figures 4.11d, 4.11f and
4.11g and Table 4.1). Thus, similarly to the results obtained by placing Ace2 and Ash1
in both mother and daughter nuclei, size control in small mother cells can be detected by
eliminating differential mother-daughter control of CLN3 expression.

Small 4xCDC28pr-CLN3 and ADH1pr-CLN3 cells in glycerol/ethanol still exhibit strong
size control (slopes of ~-0.8, compared to a theoretical expectation of -1) (Figures 4.11f,
4.11g) suggesting that while daughter-specific transcriptional regulation of CLN3 by
Ace2 and Ash1 specifies the daughter-specific set point in response to cell size, the
intrinsic mechanism of size control is not dependent on CLN3 transcription per se. We
speculate that an M/G1 burst of CLN3 expression from Mcm1 and/or Swi5 ((McInerny et
al., 1997); Fig. 4.7) may be sufficient to drive cells rapidly through T1, as is observed in
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wild-type mothers of all sizes (Figures 4.1b, 4.1c; Chapter 3); in daughters, this burst may
be suppressed by Ace2 and Ash1.

Remarkably, cells deleted for cln3 still exhibit strong effects of cell size on G1 duration,
although these effects are symmetrical between mothers and daughters of similar size
(Figures 4.11c, 4.11d). This finding emphasizes that while cell size control set points are
controlled by regulation of CLN3, there may be an underlying program of cell size
control that is Cln3-independent.

Laabs et al. (2003) reported that cln3 cells and cells expressing CLN3 from ectopic
promoters all had equal G1 durations for individual mother/daughter pairs. In our
analysis, in almost all cln3 mother-daughter pairs, with or without ectopic expression of
CLN3, the daughters had a longer T1 period. The symmetry that we observe in these
mutants is only with respect to mothers and daughters of similar size (more precisely, in
the mother and daughter plots of αT1 vs ln(Mbirth), in regions where the domains of
mothers and daughters overlap).
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Figure 4.11 Symmetric regulation of CLN3 expression results in symmetric control
of Start in mothers and daughters. Correlation between αT1 and ln (Mbirth) for cells
grown in glucose or glycerol/ethanol. (a, b) wt, (c, d) cln3, (e) cln3 6xCDC28p-CLN3, (f)
cln3 4xCDC28p-CLN3, (g) cln3 ADH1p-CLN3. Red dots: mothers, blue dots: daughters.
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Chapter 5: Discussion
The effects of molecular noise and cell size control on cell cycle variability in
budding yeast. Molecular noise in gene expression can in principle be a major
contributor of the variability of cellular systems (Samoilov et al., 2006). The role that
this noise plays in natural eukaryotic circuits in physiological conditions remains unclear.
The timing of cell cycle is variable and it is likely that both deterministic and stochastic
elements contribute to this variability (Nurse, 1980). We have used single-cell imaging
of fluorescently labeled budding yeast and a new metric for the analysis of size control to
decompose the variability of the G1 phase into variability explained by deterministic size
control and variability independent of cell size. Size-independent variability is reduced
by ploidy, compatibly with the interpretation that its main source is molecular noise, and
is the largest quantitative contributor to G1 variability. The observation that G1
variability is reduced by increasing the copy number of G1 cyclins, CLN2 and CLN3, key
rate-limiting regulators of the G1 transition, suggest that noise in their expression is one
of the leading sources of variability in the timing of the G1 phase.

While molecular noise is the largest quantitative contributor of timing variability in G1,
cell size control contributes significantly to the variability of daughter cells. This is due
to the fact that small daughter cells display efficient size control. Cell size control seems
to be independent of nutrient conditions, as cells grown in glucose and glycerol/ethanol
show similar control properties.
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Altogether, this analysis shows that molecular noise has a role in generating variability
in a cellular transition; at the same time, we provide a precise quantitative framework
demonstrating a deterministic contribution of cell size control to the same transition.

Control of the G1 phase is modular. By analyzing the nuclear localization of the
transcriptional repressor Whi5, we have found that its nuclear exit marks a landmark
event in the regulation of G1. Whi5 nuclear exit separates the control of G1 in two
modules: a size-sensing module and a size-independent timing module. The first step
depends on both Cln3 and cell size, and the second step depends on Cln2, but not on Cln3
and cell size. Temporal variability in the first step is due to the natural variability in cell
size at birth coupled with size control, as well as molecular noise, possibly due to
variability in CLN3 expression. The duration of the second step is cell-size independent;
its variability is affected by the expression of the G1 cyclin CLN2, one of the primary
final effectors of Start. Thus, our analysis decompose the regulatory dynamics of G1 into
two independent and functionally distinct modules, each of which is predominantly
controlled by a different G1 cyclin.

Analysis of the dynamics of Whi5 nuclear exit indicates that the sharp transition
between the two modules is ensured by positive feedback of Cln1 and Cln2 on their own
transcription (see Chapter 3 and (Skotheim et al., 2008)). This switch-like nature of the
Start transition may be important to ensure that cell cycle commitment is stable (Xiong
and Ferrell, 2003).
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Control of the G1 phase in mammalian cells may be characterized by a point of
commitment similar to the Start event (Morgan, 2007). It would be interesting to see if
the principles we have uncovered for the control of Start play an important role in the
control of cell cycle initiation in mammalian cells.

Cell-type-specific Start control in the budding yeast cell cycle. Asymmetric
localization of cell fate determinants during cell division is central to many
developmental programs (Horvitz and Herskowitz, 1992). Asymmetric cell division
often results in differential control of the cell cycle of the newborn cells (Horvitz and
Herskowitz, 1992; Jensen et al., 2002; Knoblich, 2008; Roegiers and Jan, 2004).

In Chapter 4, we have shown that asymmetric localization of daughter-specific
transcription factors, Ace2 and Ash1, results in differential regulation of the Start
transition in the budding yeast cell cycle. In daughter cells, Ace2 and Ash1 alter the
range of size over which cells display efficient size control, resulting in daughters
requiring an extended period of growth compared to mothers of the same size.
Mechanistically, this effect is primarily due to differential regulation of the G1 cyclin
CLN3, whose expression is lower in daughter cells at the M/G1 boundary as a result of
the presence of Ace2 and Ash1. In mothers, a ‘burst’ of CLN3 activity is sufficient to
drive them through Start even when they are small.

The biology of the budding process (Hartwell and Unger, 1977) ensures that mothers are
almost always larger then daughters; in addition, mothers have necessarily already passed
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size control, and lose little or no mass through the division process. As a consequence,
wild-type mothers essentially never display size control by our metric, even though our
analysis of ‘pseudo-mothers’ (daughter cells made mother-like by deletion of ASH1 and
ACE2) strongly suggests that mother cells do have potential ‘cryptic’ size control.

It was previously reported that asymmetric localization of Ace2 represses CLN3
expression in daughter cells (Laabs et al., 2003). Our results differ from Laabs et al.
(2003) in that we consider Ace2 regulation of CLN3 to be direct rather than indirect; also,
we incorporate interactions with Swi5 and Ash1 in CLN3 regulation. Laabs et al. (2003)
also proposed that the longer G1 of daughter cells is cell size-independent and solely a
consequence of asymmetric localization of Ace2 (Laabs et al., 2003); our results show
clearly that Ace2 and Ash1 shift the set point of cell size regulation, but strong size
control is retained independent of these factors. Thus, our results integrate the
importance of cell size in regulation of G1 length (see Chapter 3) with observations
suggesting that asymmetric transcription factors control G1 length (Laabs et al., 2003).

A new link between differentiation and cell cycle in budding yeast. In wild-type
homothallic budding yeast, only mother cells express the HO endonuclease and switch
mating type due to Ash1 repression of HO expression in daughters (Bobola et al., 1996;
Sil and Herskowitz, 1996). Phylogenetic analysis shows that in fungi, ASH1 appeared
before HO. This suggests that Ash1 may have other functions, predating mating type
switching by HO, that may be important for asymmetrical cell division. It would be
interesting to test whether Ash1 functions in cell cycle control in other fungi that can
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divide asymmetrically, such as Candida albicans, which lacks an HO homolog but
expresses an Ash1 homolog that localizes specifically to the daughter cells (Inglis and
Johnson, 2002; Munchow et al., 2002). Ash1 also is found in Ashbya gossypii, which
undergoes asynchronous division in a multinucleate syncitium (Gladfelter et al., 2006); it
would be interesting to evaluate the role of Ash1 in this asynchrony.

Ace2 controls genes that confer diverse aspects of daughter cell biology (Colman-Lerner
et al., 2001; Knapp et al., 1996; Wang et al., 2003); here we show that Ace2 also
contributes to differential Start regulation in daughters.

Cell cycle regulation and cell differentiation are inter-regulated in many systems
(Buttitta and Edgar, 2007; Jensen et al., 2002; Zhu and Skoultchi, 2001). As the decision
of cells to differentiate is often made in G1, cell differentiation and commitment to a
stable G1 are often coregulated (Buttitta and Edgar, 2007; Lasorella et al., 2006; Zhu and
Skoultchi, 2001). It would be interesting to examine cases in which stem cells produce
one proliferating cell and one daughter that differentiates in G1 (Knoblich, 2008); such
cells might employ mechanisms similar to those we have uncovered in differential
mother-daughter G1 control in budding yeast.
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Appendix: Fluorescence-based measurements of cell size

Theoretical considerations. Here, we discuss how to measure single-cell growth using
a stable fluorescent reporter expressed from a constitutively active promoter. We take R
to be the amount of immature fluorescent protein, R* to be the amount of fluorescing
protein and define k(R+ R*), where k is a constant, as cell size. The kinetics of
maturation of R into R* will be assumed to be first order with time constant τ, not
negligible compared to cell doubling time. We concentrate on two simple mathematical
models of cell growth: an exponential and a linear model. The exponential model is then
the following:

dR
1
  ( R  R* )  R
dt

*
dR
1
 R
dt 
The linear model is the following:

dR
1
  R
dt

*
dR 1
 R
dt 

The solution of these models requires the knowledge of the initial conditions R(0),
R*(0). The only quantity accessible to experiments is R*. This implies that a further
condition is necessary to solve the models. We impose the condition that the ratio of
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fluorescent and non-fluorescent proteins is constant at cell division: R*
(0)/R(0)=R*(T)/R(T), where 0 and T indicate the two successive division times. It is easy
to show that the solution of the exponential model is given by: R(t)=α τ R*(0) eαt ,
R*(t)=R*(0) eαt . This implies that for an exponential model the amount of fluorescent
protein is proportional to cell size, defined as k(R+R*). If growth is exponential, then
measures of R* can be directly used to measure cell size. This is not true for the linear
growth model, in which the ratio of R* to R is not constant during the cell cycle. We will
show below that the exponential growth model is a good model for single-cell growth in
budding yeast and will therefore use R* to measure cell size and ignore the correction
necessary for linear growth.

Data analysis We measure cell size as the total cell fluorescence from DsRed protein
expressed from the constitutively active ACT1 promoter. Background autofluorescence
was measured as the average fluorescence of unlabelled cells for each movie and
subtracted from the measured pixel intensities of labeled cells. We observed almost no
detectable red auto-fluorescence from unlabelled cells, so that the background could be
well approximated by the zero of the camera. The objective depth of field, estimated to
be 700-900 nm, was sufficiently large that the total cell fluorescence was only slightly
affected (<7%) by displacement of the objective from the plane of focus up to a distance
of 2 microns. This distance is larger than the typical error of the auto-focusing routine.

The growth of single cells as a function of time was well approximated by an
exponential. Given the limited range of changes in cell size it is hard to distinguish

82

exactly between different growth laws. Fit to linear growth was slightly but consistently
worse than an exponential fit (χ2lin ~1.2 χ2exp) and a fit with two different lines (one from
cell birth to bud and the other from bud to cell division, assuming a model in which DNA
content is limiting for cell growth) was as good as an exponential fit (χ22lines ~χ2exp).
However the two-slope fit has two more free parameters than an exponential fit (no
continuity condition was imposed on the fit).

The measurement of cell size using total red fluorescence at each time point displayed
an appreciable variability probably due to noise in the imaging process and errors in cell
body segmentation (average deviation from exponential fit 6% of the average size at
budding, Figure A1). The effect of this noise on size measurements was reduced by
extracting cell size at a given time point from the fit of exponential cell growth, instead of
using the value obtained for cell size at that frame (see Figure A1). To do this, a line was
fit to the log of cell size as function of time by the least-squares method (there is no
statistically significant deviation from linearity in these plots, as indicated by the fact that
fits to higher order polynomials do not perform any better than a linear fit). The points
(red points in Figures A1a, b, c) whose distance to the line was bigger than 2 standard
deviations (from the distribution of distances from the fitted line) were excluded and the
fit was repeated. The residuals of the fit are symmetric around zero and there is no
tendency for errors to vary between early and late points. Hence we can conclude that
there is no evidence for systematic errors and the error in size at birth or bud can be
estimated by the error on the determination of the fit parameters and time frame.
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Figure A1 Examples of the linear fit of the logarithm of cell size, M, as a function of
time and distribution of residual errors R. a), b) Examples of two fits considered
good, c) example of a bad fit that was excluded from final tabulation in the data set.
Time of budding is indicated with arrow. d) Distribution of the average distance, R, of
points from the fit. The excluded fits with R ≥ 0.10 account for about 5% of the total
number of cells.

This procedure increases the accuracy of cell size determination by 3-fold on average
(average error on single points 2% of the average size at budding).
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Occasional bad fits (residual error R ≥ 0.10) were omitted from the data (Figure A1d).
Bad fits included about 5% of the data and were mostly restricted to cells at the end of the
movie for which the segmentation software had trouble identifying the bud.

Comparison between fluorescence-based and geometrical determinations of cell
size. To compare our fluorescence based method of cell size determination with the
geometrical determination of cell size based on area (pixel number) within segmented
cell boundaries, we computed R2, the average square residual error, of an exponential fit
using the two different measures (see Figures A2a, A2b). We found that the average R2
of a fit using cell area or volume (estimated as area3/2) is about 2.2 times bigger than the
R2 obtained by using total cell fluorescence (Figures A2c, A2d). Furthermore, individual
growth rates extrapolated by using an exponential growth model for area or volume are
not in perfect agreement with the population doubling time estimated by counting cell
bodies. These observations indicate that neither area nor estimated volume is as good a
measure of cell size as cell fluorescence using ACT1pr-DsRed. We also observe that the
fluorescence measurement is more robust to changes in the position of the focal plane,
does not necessitate a cell shape model and corrects for variation in vacuole size. We
conclude that in our setup it is easier and more accurate to measure cell size with a
fluorescent marker. On the other hand, our methods are not geared to the most accurate
determination of cell volume from microscopic geometry, and while fluorescence, as we
determine it, is a better measure than cell volume extracted directly from the automated
segmenter, it is possible that another method measuring cell volume would be equivalent.

85

We have not explored this because of the ease and simplicity of our method, and its
independence of the vacuole issue.

Figure A2 Fluorescence based measurements of cell size are more accurate than
geometrical measurements. a) Example of a fit of the logarithm of cell size, M,
measured by total cell fluorescence, as a function of time, b) fit of the logarithm of cell
area, A, for the same cell as a function of time. c), d) Distribution of the ratio between
the average square distance, R2, of points from the fit of area (c) or volume (d) as a
function of time and the average square distance, R2, of points from the fit using total cell
fluorescence, demonstrating almost uniformly better fits using fluorescence.

Variability of single-cell growth rate. The single-cell growth rate α, obtained
by fitting ln(M) as a function of time as previously described, is moderately variable but
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its average agrees well with the bulk culture growth rate (Table A1), supporting the
validity of our fluorescence-based measurements of cell size.

The sources of the variability of α remain unknown.

We observe that the

variability (measured as standard deviation divided by the mean) is reduced by ploidy
(Figure A3). This reduction is statistically significant but less than √2 for each doubling
of the ploidy (Table A1). A speculation for the origin of the observed variability is that
one or more organelles or macromolecular structures important for cell growth and
present in not too high number are produced and partitioned noisily between the mother
and daughter cell. The fact that there is not significant correlation between the growth
rate of closely related cells (Figure A4) suggests that imprecision in the partitioning of
these organelles is unlikely to be the major determinant of this noise. On the other hand,
for few cells in which either the mother or the daughter is growing fast the other cell is
significantly slower (cells off the diagonal in Figure A4d). This suggests that a fastgrowing mother (daughter) may arise at the expense of a slow-growing daughter
(mother). This inverse correlation in growth rates between fast mothers (daughters) and
slow daughters (mothers) may in part be explained by imprecise partitioning of
organelles present in small numbers.

It deserves to be mentioned that while the average growth rate in our setup for
cells in glucose is 100 minutes we can observe occasional cells (about 5% in haploids)
that double their mass in about 70 minutes. The fact that the fast-growing cells are
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accompanied by slow growing ones could explain why yeast do not grow at this faster
rate.

wt haploids
wt diploids
wt tetraploids
6xCLN2
6xCLN3
6xCLN3 6xCLN2

Measured doubling Doubling time
time
predicted from
individual cells
growth rate
99±1
100±1
95±1
93±1
101±2
97±2
104±3
103±3
103±1
105±2
106±3
107±3

Coefficient of
variation of growth
rates
0.18±0.02
0.14±0.01
0.13±0.01
0.17±0.02
0.21±0.03
0.17±0.03

Table A1 Comparison between colony doubling time and doubling time predicted
from measurements of growth rate of individual cells. The table shows the mean +/standard error of the mean in minutes.

Figure A3 Distribution of growth rates for various strains. The average growth rate
<α> agrees well with the colony growth rate (see Table A1).
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Figure A4 Growth rates of individual cells are not inherited. a) Schematics of growth
rate inheritance analysis (=ln(2)/). b), c), d) Correlation between the growth rates of
closely related cells. The red lines are the identity lines.
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